Animace načítání

Stránka se připravuje...

Přihlásit se Registrovat se
28 595 právních předpisů

Další údaje zde

Technická podpora

Poskytujeme technickou podporu zdarma

Zavolejte nám

+420 777 717 492

Plné znění - 32019R0831

  1. Úvodní strana
  2. Právní předpisy EU
  3. Plné znění - 32019R0831

Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Chci získat výhodný přístup

XXXXXXXX XXXXXX (XX) 2019/831

xx xxx 22. května 2019,

xxxxxx xx xxxx xxxxxxx II, III x X xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (ES) č. 1223/2009 x xxxxxxxxxxxx xxxxxxxxxxx

(Xxxx x xxxxxxxx pro XXX)

XXXXXXXX XXXXXX,

x xxxxxxx xx Xxxxxxx x xxxxxxxxx Xxxxxxxx unie,

x xxxxxxx xx nařízení Xxxxxxxxxx xxxxxxxxxx a Rady (ES) x. 1223/2009 xx xxx 30. xxxxxxxxx 2009 x xxxxxxxxxxxx xxxxxxxxxxx (1), x xxxxxxx na čl. 15 xxxx. 1, xx. 15 xxxx. 2 xxxxxx pododstavec a čl. 31 xxxx. 1 uvedeného xxxxxxxx,

xxxxxxxx x xxxxx důvodům:

(1)

Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx (XX) x. 1272/2008 (2) xxxxxxx xxxxxxxxxxxxxx xxxxxxxxxxx xxxxx xxxx xxxxx karcinogenních, mutagenních xxxx xxxxxxxxx xxx xxxxxxxxxx (XXX) xx xxxxxxx xxxxxxxxx posouzení Xxxxxx xxx xxxxxxxxxx xxxxx Xxxxxxxx xxxxxxxx xxx xxxxxxxx xxxxx. Xxxxx xxxx klasifikovány xxxx látky XXX xxxxxxxxx 1 X, xxxxx XXX kategorie 1X xxxx látky CMR xxxxxxxxx 2 x xxxxxxxxxx xx xxxxxx xxxxxx x xxxxxx vlastnostech CMR.

(2)

Xxxxxx 15 xxxxxxxx (ES) x. 1223/2009 xxxxxxxx používat x xxxxxxxxxxxx xxxxxxxxxxx látky xxxxxxxxxxxxx podle části 3 přílohy VI xxxxxxxx (XX) č. 1272/2008 (xxxxx XXX) xxxx xxxxx CMR xxxxxxxxx 1 X, xxxxxxxxx 1X xxxx xxxxxxxxx 2. Xxxxx CMR však xxxx být x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxx, xxxxx xxxx xxxxxxx xxxxxxxx xxxxxxxxx v čl. 15 xxxx. 1 xxxxx xxxx nebo x xx. 15 odst. 2 druhém xxxxxxxxxxx xxxxxxxx (ES) x. 1223/2009. Xxxxx xxxxxxxxx xx xxxxxxx xxxxxxxx (XX) x. 1223/2009. Vykládat xxxxx Xxxx, včetně xxxxxx 15 nařízení (XX) x. 1223/2009, xx xxxxxxxx xxxxx Soudní xxxx Xxxxxxxx unie.

(3)

X xxxxx jednotného xxxxxxxxx zákazu látek XXX x xxxxx xxxxxxxxx xxxx, zajištění xxxxxx xxxxxxx xxxxxxx xxx xxxxxxxxxxx xxxxxxxx a příslušné xxxxxxxxxxxx xxxxxx, xxxxx x xxxxxxxxx xxxxxx xxxxxx xxxxxxx xxxxxxxx zdraví xx xxxxxxx xxxxx XXX měly xxx xxxxxxxx xx seznam xxxxxxxxxx xxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx vyňaty xx xxxxxxx látek xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX a V uvedeného nařízení. Xxxxx xxxx splněny xxxxxxxx xxxxxxxxx x xx. 15 xxxx. 1 xxxxx větě xxxx x xx. 15 xxxx. 2 xxxxxx xxxxxxxxxxx nařízení (XX) x. 1223/2009, seznamy xxxxx xxxxxxxxxxxxx omezení xxxx xxxxxxxxxx xxxxx x xxxxxxxxx XXX x X xxxxxxxxx xxxxxxxx xx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(4)

Xxxx nařízení xx xxxxxxxx xx xxxxx, xxxxx byly xxxxx xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxxx xxxx xxxxx XXX xx xxx 1. xxxxxxxx 2018, xxx xx xxxxx použitelným xxxxxxxx Xxxxxx (XX) 2017/776 (3).

(5)

Xxxxx xxx o určité xxxxx XXX, xxx xxx xxxx xxxxxxxxxx žádost x xxxxxxxxx xxxxxxx v kosmetických xxxxxxxxxxx, nebylo stanoveno, xx jsou splněny xxxxxxx xxxxxxxx xxxxxxxxxx x xx. 15 xxxx. 1 xxxxx xxxx xxxx x xx. 15 xxxx. 2 druhém xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Xx xx xxxx xxxxx Quaternium-15, Chloroacetamide, xxxxxxxxxxxxxx, xxxxxxxxxxxx, sloučenin xxxxxxxx perborité a perboritanů xxxxxxx.

(6)

Xxxxx xxxxxxxxxx-3-xxxxxxxxxxxxxxxxx, xxxxx xxxxx xxxxx Xxxxxxxxxxx xxxxxxxxxxxx kosmetických přísad (XXXX) zní Xxxxxxxxxx-15, xx v současné době xxxxxxx x xxxxxxx 31 xxxxxxx V nařízení (XX) x. 1223/2009 jako látka xxxxxxxx x xxxxxxxxxxx xx 0,2 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Látka Xxxxxxxxxx-15 xx xxxx xxx- x xxxxx-xxxxxxx, xxxxx xxx-xxxxxx xxx xxxxxxxxx Xxxxxx (XX) č. 790/2009 (4) xxxxxxxxxxxx xxxx xxxxx XXX kategorie 2. Xxxx klasifikace xx xxxxx xxxxxxxxxxx dne 1. xxxxxxxx 2010. X xxxxxxx x xx. 15 xxxx. 1 xxxxxx větou xxxxxxxx (XX) x. 1223/2009 xxxx xxx látka xxxxxxxxxxxxx xxxx xxxxxxxxx 2 xxxxxxx v kosmetických xxxxxxxxxxx, xxxx-xx xxxxxxxxxx Xxxxxxxx výborem xxx xxxxxxxxxx xxxxxxxxxxxx (dále xxx „XXXX“) x xxxxxxxx xxxx xxxxxxxx xxx xxxxxxx v kosmetických přípravcích. Xx dnech 13. x 14. xxxxxxxx 2011 vydal XXXX xxxxxxx xxxxxxxxxx týkající xx xxxxx Xxxxxxxxxx-15 (xxx-xxxxxx) (5), xx xxxxxx xxxxxx x xxxxxx, xx xx xxxxxxx dostupných xxxxx xxxxx stanovit xxxxxxxxxx použití látky Xxxxxxxxxx-15 x xxxxxxxxxxxx xxxxxxxxxxx. X xxxxxxx xx xxxxxxxxxxx xxx-xxxxxxx xxxxxxxxxx x xxxxx Xxxxxxxxxx-15 xxxx látky XXX xxxxxxxxx 2 x xx xxxxxxxxxx XXXX xx měla xxx xxxxx Quaternium-15 vyňata xx seznamu xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxx xx seznam látek xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(7)

Xxxxx 2-xxxxxxxxxxxxx, xxxxx xxxxx xxxxx XXXX xxx Chloroacetamide, je x xxxxxxxx době uvedena x xxxxxxx 41 xxxxxxx X xxxxxxxx (ES) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx do 0,3 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. Xxxxx Xxxxxxxxxxxxxxx xxxx xxxxx xxxxxxxx (XX) x. 1272/2008 xxxxxxxxxxxxx xxxx xxxxx CMR xxxxxxxxx 2. Xxxx xxxxxxxxxxx xx stala použitelnou xxxx 1. xxxxxxxxx 2010, xxx xx datum, xxx xx xxx xxxxx xxxxx použitelná xxxxxxxxxx xxxx II, XXX x XX xxxxxxxx (XX) x. 1272/2008. V souladu x xx. 15 xxxx. 1 xxxxxx xxxxx nařízení (ES) x. 1223/2009 xxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxxxxxx 2 xxxxxxx x xxxxxxxxxxxx přípravcích, byla-li xxxxxxxxxx VVBS x xxxxxxxx xxxx xxxxxxxx xxx xxxxxxx x xxxxxxxx xxxxxxxxxxx. Xxx 22. xxxxxx 2011 vydal XXXX xxxxxxx stanovisko xxxxxxxx xx látky Xxxxxxxxxxxxxxx (6), xx kterém xxxxxx k závěru, xx xx xxxxxxx xxxxxxxxxx xxxxx není tato xxxxx při použití x xxxxxxxxxxx do 0,3 % xxxxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxx xxxxxxxxxxxx bezpečná. X xxxxxxx na xxxxxxxxxxx xxxxx Chloroacetamide jako xxxxx CMR xxxxxxxxx 2 x xx xxxxxxxxxx XXXX by xxxx xxx tato xxxxx xxxxxx xx xxxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx v příloze X xxxxxxxx (XX) č. 1223/2009 x xxxxxxxx xx seznam xxxxx zakázaných x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(8)

Xxxxx xxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx x xxxxxxx 7 xxxxxxx XXX nařízení (XX) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxxxxxx xx 35 % v přípravku xxxxxxxxxxx x xxxxxxx. Xxxxxxxxxxxxx xxx xxxxx nařízení (XX) x. 1272/2008 klasifikován xxxx xxxxx XXX xxxxxxxxx 2. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxxx 1. xxxxxxxxx 2010. X xxxxxxx x xx. 15 xxxx. 1 xxxxxx xxxxx xxxxxxxx (XX) č. 1223/2009 xxxx xxx xxxxx klasifikovaná xxxx xxxxxxxxx 2 xxxxxxx v kosmetických xxxxxxxxxxx, xxxx-xx xxxxxxxxxx XXXX x xxxxxxxx xxxx bezpečná xxx xxxxxxx x xxxxxxxx xxxxxxxxxxx. Dne 11. xxxxxxxx 2012 xxxxx XXXX xxxxxxx xxxxxxxxxx xxxxxxxx se xxxxx xxxxxxxxxxxxx (7). Dne 25. xxxxxx 2015 xxxxx XXXX xxxx stanovisko (8), které xxxx xxxxxxxxxx xxx 28. xxxxx 2015. X xxxxx revidovaném xxxxxxxxxx xxxxxx XXXX x xxxxxx, že xxxxxxxxx xxxxxxxxxxxxxx v koncentraci xx 35 % v lacích xx xxxxx x xxxx použití xx xxxxxxxx xxxxxx xxxx xxxxxxxxxx za xxxxxxxx pro spotřebitele. X xxxxxxx xx xxxxxxxxxxx xxxxxxxxxxxxxx jako látky XXX xxxxxxxxx 2 x xx xxxxxxxxxx XXXX x xxxxxxxx k tomu, že xxxxxx xxxxx a ve xxxxxxxxxx XXXX xxxxxxxxx xxxxx xxxxx xxxxxxx xxxxxxxxxxxxxx v kosmetických přípravcích, xx tato xxxxx xxxx xxx xxxxxx xx xxxxxxx látek xxxxxxxxxxxxx xxxxxxx v příloze XXX nařízení (XX) x. 1223/2009 x xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX uvedeného xxxxxxxx.

(9)

Xxxxx xxxxxxxxxxx je x xxxxxxxx xxxx xxxxxxx v položce 13 přílohy XXX xxxxxxxx (ES) x. 1223/2009 xxxx xxxxx xxxxxxxx x xxxxxxxxxxx xxx tvrzení xxxxx x xxxxxxxxxxx xx 5 % x xxxxxxxxx xxxxxxxxxxx x xxxxxxx. X xxxxxxxx xxxx xx xxxx uvedena x xxxxxxx 5 xxxxxxx X xxxxxxxx (XX) č. 1223/2009 xxxx xxxxx povolená x xxxxxxxxxxx xxx xxxxx xxxxxxx x xxxxxxxxxxx xx 0,1 % x x xxxxxx xxxxxxxxxxx x xxxxxxxxxxx do 0,2 %. Xxxxxxxxxxx byl xxxxxxxxxxxx xxxx látka XXX xxxxxxxxx 1X xxxxxxxxx Xxxxxx (XX) č. 605/2014 (9). Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. xxxxx 2016. X xxxxxxx s čl. 15 xxxx. 2 druhým xxxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 1 A xxxx 1X x xxxxxxxxxxxx xxxxxxxxxxx výjimečně xxxxxxx, xxxxx xxxx poté, xx byly xxxxxxxxxxxxx xxxx xxxxx XXX, xxxxxxx xxxxxx podmínky xxxxxx xxxxxxxx, xx xxxxxx x xxxxxxxxx žádné xxxxxx alternativní xxxxx, xx xxxx xxxxxx xxxxxx xx xxxxxx xxxxxxx kategorie přípravku xx xxxxxx xxxxxxxx x xx byla xxxx xxxxx VVBS xxxxxxxxxx x xxxxxxxx jako bezpečná. Xxx 7. listopadu 2014 xxxxxx XXXX xx svém xxxxxxxxxx (10) x xxxxxx, xx „xxx tvrzení xxxx xxxxxxxx nehtů xxxxx xxx bezpečně xxxxxxx xxxxxxxxx xxx tvrzení xxxxx x xxxxxxxx koncentraci xxxxxx 2,2 % xxxxxxx xxxxxxxxxxxx“. Protože xxxx xxxxxx stanoveno, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx xxxxxxxxxxxx látky xxx tvrzení nehtů, xxx by xxx xxxxxxxxxxx vyňat xx xxxxxxx látek xxxxxxxxxxxxx xxxxxxx v příloze XXX xxxxxxxx (ES) č. 1223/2009. Xxxxxxxx k tomu, xx xxxxxx podána xxxxxx xx jiná použití xxxxxxxxxxxx, měla xx xxx xxxx xxxxx xxxxxx ze seznamu xxxxxxxxxxxxx přísad povolených x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxxx xxxxxxxx. Xxxxxxxxxxx xx xxx xxx xxxxxx xxxxxxx xx xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx XX xxxxxxxx (ES) x. 1223/2009.

(10)

Xxxxxxxxxx xxxxxxxx xxxxxxxxx x xxxxxxxxxxx sodné xxxxx xxxx látky uvolňující xxxxxxx xxxxxx, xxxxx xxxx v současné xxxx xxxxxxx v položce 12 xxxxxxx XXX nařízení (XX) x. 1223/2009. Xxxx xxxxx byly klasifikovány xxxx látky XXX xxxxxxxxx 1B xxxxxxxxx (XX) x. 790/2009. Tato xxxxxxxxxxx xx stala xxxxxxxxxxx xx xxx 1. xxxxxxxx 2010. Xx xxxxxxx xxxxxx látek x xxxxxxxxxx xxxxxxxxxxx k barvení xxxxx xxxx xxxxxx žádost x xxxxxxxxx xx. 15 xxxx. 2 xxxxxxx xxxxxxxxxxx xxxxxxxx (XX) x. 1223/2009. Xxx 22. xxxxxx 2010 xxxxxx VVBS xx xxxx xxxxxxxxxx (11) x xxxxxx, že „xxxxxx xxxxxxx platná xxx xxxxx, xxxxx xxxxxxxx xxxxxxx vodíku, xx xx xxxx xxxxxxxxx xx perboritan xxxxx x xxxxxxxx perboritou x xx xxxxxxx xxxxxxxxxxx xxxxxxx xxxx xxxxxx x xxxxxxxxxx xxxxxxxxxxx k barvení xxxxx x xxxxxxxxxxx xxxxxxx 3 % xx xxxxx xxxxxxxxxxxxx xxxxxx xxx xxxxxx xxxxxxxxxxxx“. Xxxxxxx xxxx xxxxxx stanoveno, že xxxxxx k dispozici xxxxx xxxxxx xxxxxxxxxxxx xxxxx xxx účely xxxxxxx xxxxx, sloučeniny kyseliny xxxxxxxxx x xxxxxxxxxxx sodné xx xxxx být xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx III xxxxxxxx (XX) x. 1223/2009 a doplněny xx seznam látek xxxxxxxxxx v kosmetických xxxxxxxxxxx x xxxxxxx XX xxxxxxxxx xxxxxxxx.

(11)

Xxxxx jde x xxxxxx xxxxx, xxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxx nařízení (XX) x. 1272/2008 x xxx xxx xxxx xxxxxx xxxxxx x xxxxxxxxx xx. 15 xxxx. 1 xxxxx xxxx xxxxxxxx (XX) č. 1223/2009, xxxx stanoveno, xx xxxxxxxx xxxxxxxxx v uvedeném xxxxxxxxxx xx splněna. Xx xx xxxx xxxxx Trimethylbenzoyl diphenylphosphine xxxxx, Xxxxxxxx a Polyaminopropyl xxxxxxxxx.

(12)

Xxxxx xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx, xxxxx xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxxx xxxxxxxxxxxxxxxxx xxxxx (XXX), xxxx x xxxxxxxx xxxx xx xxxxxx xxxxxxxx (XX) č. 1223/2009 xxxxxxxx. Xxxx látka byla xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 2 xxxxxxxxx Komise (XX) x. 618/2012 (12). Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xxx 1. prosince 2013. Xxx 27. xxxxxx 2014 xxxxx XXXX xxxxxxx xxxxxxxxxx (13), v němž xxxxxx x xxxxxx, že xxxxx TPO xx xxxxxxxx xxx použití xxxx xxxxxxxxx k modeláži xxxxx v koncentraci do 5,0 %, xxxxx xx xxx x xxxxx xxxxx xxxxxxxxxxxxxxx xxxx. Xxxxxxxx x xxxxxxxxxxxxxxxx účinkům TPO xx xxxx x xxxxxxxx xxxxxx xxxxxxxx v důsledku xxxxx s kůží xxx xxxxxxxx xxxxxxxxx xx xxxxx xxxxxxxxx xxxxxxxxxxxx xx používání XXX xxxx xxx omezeno xx xxxxxxxxxxxxx xxxxxxxxx. X xxxxxxx na tyto xxxxxxxxxxx xx xxxxx XXX měla xxx xxxxxxxx na xxxxxx xxxxx podléhajících omezení x xxxxxxx XXX xxxxxxxx (XX) č. 1223/2009 xxx xxxxxxxxxxxxx použití x xxxxxxxxx xxxxxxx nehtů v koncentraci xxxxxxx 5 %.

(13)

Látka 2-furaldehyd, xxxxx xxxxx podle XXXX xxx Furfural, xx xxxxxxx xxxx xxxxx nebo xxxxxxxxxx xxxxxx v kosmetických xxxxxxxxxxx x x xxxxxxxx xxxx xxxx xxxxxxxx do xxxxxx xxxxxxxx (ES) č. 1223/2009. Xxxx xxxxx xxxx xxxxxxxxxxxxx xxxx xxxxx XXX kategorie 2 xxxxx nařízení (XX) x. 1272/2008. Xxxx xxxxxxxxxxx xx xxxxx použitelnou xxxx 1. xxxxxxxxx 2010. Xxx 27. xxxxxx 2012 xxxxxx XXXX xx svém xxxxxxxxxx (14) x xxxxxx, že xxxxxxx xxxxx Xxxxxxxx x xxxxxxxxxxx xx 10 xxx (0,001 %) x xxxxxxxxx xxxxxxxxxxx k použití, xxxxxx xxxxxxxxx pro xxxxx xxxxxxx, xxxxxxxxxxxxx xxxxxx xxx xxxxxx spotřebitele. X xxxxxxx xx xxxxxxxxxxx xxxxx Xxxxxxxx jako xxxxx XXX kategorie 2 x xx stanovisko XXXX xx xxxxx Xxxxxxxx v koncentraci xxxxxxx 0,001 % měla být xxxxxxxx xx seznam xxxxx xxxxxxxxxxxxx omezení x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009.

(14)

Xxxxx xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx (XXXX), xxxxx xxxxx xxxxx XXXX xxx Xxxxxxxxxxxxxxx biguanide, xx x xxxxxxxx xxxx xxxxxxx xx seznamu jako xxxxxxxxxxx přísada x xxxxxxx 28 xxxxxxx X xxxxxxxx (XX) x. 1223/2009 x xxxxxxxxxxx xxxxxxx 0,3 %. Xxxx xxxxx xxxx klasifikována xxxx xxxxx XXX xxxxxxxxx 2 xxxxxxxxx Xxxxxx (EU) x. 944/2013 (15). Xxxx xxxxxxxxxxx se xxxxx xxxxxxxxxxx dne 1. xxxxx 2015. Xxx 18. xxxxxx 2014 xxxxxx XXXX stanovisko (16), xx xxxxxx xxxxxx x xxxxxx, že xx xxxxxxx xxxxxxxxxx údajů xxxxx xxxxx XXXX xxxxxxxxx xx xxxxxxxxx xxx spotřebitele, pokud xx v koncentraci xxxxxxx 0,3 % použita xxxx xxxxxxxxxxx xxxxxxx v jakémkoliv xxxxxxxxxxx přípravku. Xx xxxx xxxxxxxxxx xxxx XXXX xxxxxx xxxxxx x xxxxxx, xx bezpečné xxxxxxx by mohlo xxx xxxxxxxx xx xxxxx xxxxxxxxxxx použití x/xxxx xxxxxxx, pokud xxx x xxxxxxxxx xxxxxxxxxxxx xxxxxxxxx, x xx xxxx xxxxxxxxx xxxxxx dermální xxxxxxxx týkající xx xxxxxxx reprezentativních kosmetických xxxxxxxxx. Dne 7. xxxxx 2017 xxxxxx XXXX xxxx xxxxxxxxxx (17), xx kterém xxxxxx k závěru, xx xx xxxxxxx xxxxxxxxxxxx xxxxx xx použití XXXX xxxx xxxxxxxxxxx xxxxxxx xx všech xxxxxxxxxxxx přípravcích x xxxxxxxxxxx xx 0,1 % xxxxxxxx xx bezpečné, xxx xxxx použití xx xxxxxxxx xx xxxxxxxxxxxx. X xxxxxxx na xxxxxxxxxxx XXXX jako látky XXX xxxxxxxxx 2 x xx nové xxxxxxxxxx XXXX xx látka XXXX měla xxx xxxxxxxx xxxx konzervační xxxxxxx xx xxxxx xxxxxxxxxxxx xxxxxxxxxxx, x xxxxxxxx xxxxxxxx, jež mohou xxxx x xxxxxxxx xxxx xxxxxxxxx xxxxxxxxx xxx xxxxxxxxxx, x xxxxxxxxxxx xxxxxxx 0,1 %. Xxxxxxxx stanovené x xxxxxxx X xxxxxxxx (XX) x. 1223/2009 by xxxxx xxxx být odpovídajícím xxxxxxxx xxxxxxx.

(15)

Pokud xxx x xxxxxx skupinu xxxxx, xxxxx byly xxxxxxxxxxxxx xxxx látky XXX xxxxx nařízení (XX) x. 1272/2008, xxxxx xxxxxx xx xxxxxxxxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xxxxxx xxxxxxxxxx. Tyto látky xx xxxx xxx xxxxxxxx xx xxxxxx xxxxxxxxxx xxxxx x xxxxxxx XX nařízení (XX) x. 1223/2009 x xxxxxxxx xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxxxx xxxxx v přílohách XXX a V uvedeného xxxxxxxx. Xx xx xxxx xxxx xxxx některých xxxxxxxxx xxxx, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx x xxxxxxxxx 1x x 1x xxxxxxx III xxxxxxxx (XX) x. 1223/2009.

(16)

Xxxxxxx xxxxxxxxxx boru, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx v položkách 1x x 1x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009, x xxxxxxxxxx-xxxxxxxxxxxxx xxxx xxxxxxxxx (XX) x. 790/2009 xxxxxxxxxxxxx xxxx látky XXX xxxxxxxxx 1B. Xxxx xxxxxxxxxxx se xxxxx xxxxxxxxxxx ke xxx 1. xxxxxxxx 2010. V souladu s čl. 15 xxxx. 2 druhým xxxxxxxxxxxx xxxxxxxx (ES) x. 1223/2009 xxxxx xxx xxxxx xxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 A xxxx 1B x xxxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxx, xxxxx xxxx xxxx, xx byly klasifikovány xxxx xxxxx CMR, xxxxxxx xxxxxx podmínky. Xxx 22. xxxxxx 2010 xxxxx XXXX stanovisko (18), x xxxx xxxxxx x xxxxxx, že xxxxxxx sloučeniny xxxx, xxxxx xxxx x xxxxxxxx xxxx xxxxxxx x xxxxxxxxx 1x x 1x xxxxxxx XXX xxxxxxxxx xxxxxxxx, xxxx xxx xxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx xx xxxxxxxx xxxxxxxx xxxxxxxx. Xxxxxxx nebyla xxxxxx xxxxxx xx xxxxxx xxxxxxx x xxxxxx xxxxxxxxx, xx xxxxxx x xxxxxxxxx xxxxx xxxxxx alternativní xxxxx xxx účely xxxxxxxxxxxx použití uvedených x xxxxxxx XXX xxxxxxxx (XX) x. 1223/2009, xxxx xx být uvedené xxxxxxxxxx boru vyňaty xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx XXX xxxxxxxxx nařízení x xxxxxxxx na xxxxxx xxxxx xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxx (XX) č. 1223/2009. Xxxxx xxx x xxxxxxxxxx-xxxxxxxxxxxxx, xxxxxx xxxxxx xxxxxx xx xxxxxx xxxxxxx x XXXX ji xxxxxxxxx xxxx bezpečnou. Xxxxxxx xxxxx xx proto xxxx xxx xxxxxxxx xx xxxxxx látek xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx XX xxxxxxxx (XX) x. 1223/2009.

(17)

Xxxxxxxxxx xx. 31 xxxx. 1 xxxxxxxx (XX) x. 1223/2009 xxxxxxx, že xxxxxxxxxxx-xx xxxxxxx xxxxxxxx xxxxx x xxxxxxxxxxxx přípravcích xxxxxxxxxxx xxxxxx xxx xxxxxx zdraví, xxxxx xxxxxxxx xxxxx xx xxxxxx Xxxxxxxxxxxx, xxxx Xxxxxx xx konzultaci x XXXX xxxxxxxxxxxxx xxxxxxxx xxxxxx xxxxxxx XX xx XX xxxxxxxxx xxxxxxxx. Xxxxxx xxxxxxxxxxxx XXXX xxxxxxx xxxxxxxxxxx xxxxxxxx látek, xxxxx xxxx x xxxxxxxxxx xxxxxxxx xxxxxxx xxxxxx xxxxxxxxxxxxxx xxxx xxxxx XXX xxxxxxxxx 1 A, 1B xxxx 2. Xx xx xxxx xxxxxxxx xxxxxxxxx boru, xxxxx x xxxxx xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx.

(18)

Xxxxxxx xxxxxxxxxx boru, x xxxxxxxx xxxx xxxxxxx x xxxxxxxxx 1x a 1b přílohy XXX xxxxxxxx (ES) x. 1223/2009, xxxx než xxxxxxxxxx uvedené v 16. xxxx odůvodnění, nebyly xxxxxxxxxxxxx jako xxxxx XXX. Xxx 12. xxxxxxxx 2013 xxxxx XXXX xxxxxxxxxx xxxxxxxx se boritanů, xxxxxxxxxxxxx a oktaboritanů (19), xx xxxxxx xxxxxx k závěru, xx xx uvedené xxxxx, xxxxxx xxxx xxxxxxx xxxx xxxx xxxxxx xxxxxxxx xxxxxx, xxxx xx MEA-borát, XXXX-xxxxxxx, xxxxxxx xxxxxxxx, xxxxxxxxxxxxxxx-xxxxx x xxxxxxx xxxxxxxxx, xxxxxxxxx xx xxxxxxx xxxxxxxxx na xxxxxxxx xxxxxxx, a proto by xx obecná xxxxxxx xxxxxx xxx kyselinu xxxxxxx xxxx xxxxxxxxx xx xxxxx skupinu xxxxxxxx, xxxxxxxxxxxxx a oktaboritanů. Xxxxxxxx xxxxxx xxxx xxxxxxxxx (XX) x. 790/2009 xxxxxxxxxxxxx jako xxxxx XXX xxxxxxxxx 1X. Xxxx xxxxxxxxxxx xx xxxxx xxxxxxxxxxx xx xxx 1. prosince 2010. Xxxx xxxxxxx boritanů, xxxxxxxxxxxxx x xxxxxxxxxxxx, s výjimkou látek x xxxxxxx skupině, xxxxx xxxx klasifikovány jako xxxxx XXX, xxxxxx xxxx xxxxxxx xxxx xxxx xxxxxx kyseliny xxxxxx xx xxxx xxx s ohledem xx xxxxxxxxxx XXXX xxxxxx xx xxxxxxx xxxxx xxxxxxxxxxxxx omezení x xxxxxxx XXX xxxxxxxx (ES) x. 1223/2009 a doplněny xx xxxxxx xxxxx zakázaných x xxxxxxxxxxxx přípravcích v příloze XX xxxxxxxxx xxxxxxxx.

(19)

Látka xxxxxxxxxxxxxxx xx x xxxxxxxx xxxx xxxxxxx na xxxxxxx v položce 5 xxxxxxx X xxxxxxxx (XX) x. 1223/2009, avšak na xxxxxx xx xxxxxxxxxxxx xxxxxx klasifikována jako xxxxx XXX. Látka xxxxxxxxxxxxxx xxxx v současné xxxx xx příloh xxxxxxxx (XX) č. 1223/2009 xxxxxxxx. Xx dnech 26. x 27. xxxxxx 2012 přijal XXXX xxxxxxxxxx xxxxxxxx xx xxxxxxxxxxxxxxx (20), ve xxxxxx xxxxxxxx, xx xxxxxxxxxxxxxx xx xx xxxx různých podmínek xxxxxx xxxxxxxxxxxx, xxx xxxx k jeho přeměně xx xxxxxxxxxxx ve xxxxxxx roztocích, x xx xxxxxxxxxxxxxxx xxxx xxxxxxxxxxxxxxx, xxx xxxx k jeho xxxxxxx xx xxxxxxxxxxx xxxxxxxx nebo xxxxxxx. X xxxxxxx xx xxxxxxxxxx XXXX xxxxxxxx xxxxxxxxxxx xxxxxx pro xxxxxx xxxxxx vyplývající z použití xxxxxx látek x xxxxxxxxxxxx xxxxxxxxxxx. Paraformaldehyd by xxxxx měl xxx xxxxx xx xxxxxxx xxxxxxxxxxxxx přísad xxxxxxxxxx x xxxxxxxxxxxx xxxxxxxxxxx x xxxxxxx X xxxxxxxx (XX) č. 1223/2009 x xxxxxxxxxxxxxxx x xxxxxxxxxxxxxx by xxxx být doplněny xx seznam látek xxxxxxxxxx x xxxxxxxxxxxx přípravcích x xxxxxxx II xxxxxxxxx xxxxxxxx.

(20)

Xxxxxxxx (ES) x. 1223/2009 xx xxxxx xxxx xxx xxxxxxxxxxxxx xxxxxxxx xxxxxxx.

(21)

Xxxxxxxx xxxxxxxxx tímto xxxxxxxxx jsou v souladu xx xxxxxxxxxxx Xxxxxxx xxxxxx xxx xxxxxxxxxx xxxxxxxxx,

XXXXXXX XXXX XXXXXXXX:

Xxxxxx 1

Xxxxxxx XX, III x X xxxxxxxx (XX) x. 1223/2009 xx xxxx x xxxxxxx x xxxxxxxx xxxxxx nařízení.

Xxxxxx 2

Xxxx xxxxxxxx xxxxxxxx x xxxxxxxx dvacátým dnem xx vyhlášení x Xxxxxxx xxxxxxxx Xxxxxxxx xxxx.

Xxxx xxxxxxxx xx xxxxxxx x xxxxx xxxxxxx x xxxxx použitelné ve xxxxx xxxxxxxxx xxxxxxx.

V Bruselu xxx 22. xxxxxx 2019.

Za Xxxxxx

xxxxxxxx

Xxxx-Xxxxxx XXXXXXX

(1)  Úř. věst. L 342, 22.12.2009, s. 59.

(2)  Nařízení Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 xx xxx 16.&xxxx;xxxxxxxx&xxxx;2008 x&xxxx;xxxxxxxxxxx, označování a balení xxxxx x&xxxx;xxxxx, x&xxxx;xxxxx x&xxxx;xxxxxxx xxxxxxx 67/548/XXX x&xxxx;1999/45/XX x&xxxx;x&xxxx;xxxxx xxxxxxxx (XX) x.&xxxx;1907/2006 (Xx.&xxxx;xxxx.&xxxx;X&xxxx;353, 31.12.2008, x.&xxxx;1).

(3)&xxxx;&xxxx;Xxxxxxxx Xxxxxx (XX) 2017/776 xx xxx 4.&xxxx;xxxxxx&xxxx;2017, xxxxxx xx xxx xxxxx xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Evropského parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, označování a balení xxxxx a směsí (Xx.&xxxx;xxxx.&xxxx;X&xxxx;116, 5.5.2017, x.&xxxx;1).

(4)&xxxx;&xxxx;Xxxxxxxx Komise (XX) x.&xxxx;790/2009 xx dne 10.&xxxx;xxxxx&xxxx;2009, kterým xx xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (ES) č. 1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí (Úř. věst. L 235, 5.9.2009, x.&xxxx;1).

(5)&xxxx;&xxxx;XXXX/1344/10, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_077.xxx.

(6)&xxxx;&xxxx;XXXX/1360/10, http://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_053.pdf.

(7)&xxxx;&xxxx;XXXX/1408/11, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_118.xxx

(8)&xxxx;&xxxx;XXXX/1547/15, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_170.xxx

(9)  Nařízení Xxxxxx (EU) x.&xxxx;605/2014 ze xxx 5.&xxxx;xxxxxx&xxxx;2014, xxxxxx xx xxx xxxxx zařazení xxxxxxxxxxxx xxxxxx xxxxxxxxxx xx xxxxxxxxxxxxx a bezpečného xxxxxxxxx x&xxxx;xxxxxxxxxxxx a přizpůsobení xxxxxxx-xxxxxxxxxxx xxxxxxx mění xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Xx.&xxxx;xxxx.&xxxx;X&xxxx;167, 6.6.2014, x.&xxxx;36).

(10)&xxxx;&xxxx;XXXX/1538/14, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_164.pdf

(11)&xxxx;&xxxx;XXXX/1345/10, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_031.xxx

(12)  Nařízení Xxxxxx (EU) x.&xxxx;618/2012 xx xxx 10.&xxxx;xxxxxxxx&xxxx;2012, kterým xx xxx xxxxx xxxxxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx a směsí (Úř. věst. L 179, 11.7.2012, x.&xxxx;3).

(13)&xxxx;&xxxx;XXXX/1528/14, xxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_149.xxx.

(14)&xxxx;&xxxx;XXXX/1461/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_083.xxx

(15)  Nařízení Xxxxxx (XX) x.&xxxx;944/2013 ze xxx 2.&xxxx;xxxxx&xxxx;2013, kterým xx xxx účely xxxxxxxxxxxx xxxxxxxxxxxxxxxxxx xxxxxxx xxxx xxxxxxxx Xxxxxxxxxx parlamentu x&xxxx;Xxxx (XX) x.&xxxx;1272/2008 x&xxxx;xxxxxxxxxxx, xxxxxxxxxx x&xxxx;xxxxxx xxxxx x&xxxx;xxxxx (Úř. věst. L 261, 3.10.2013, s. 5).

(16)&xxxx;&xxxx;XXXX/1535/14, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_157.xxx

(17)&xxxx;&xxxx;XXXX/1581/16, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxx/xxxxxx/xxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_204.xxx

(18)&xxxx;&xxxx;XXXX/1249/09, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_027.pdf

(19)&xxxx;&xxxx;XXXX/1523/13, https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_o_146.pdf

(20)  SCCS/1483/12, xxxxx://xx.xxxxxx.xx/xxxxxx/xxxxxxxxxx_xxxxxxxxxx/xxxxxxxx_xxxxxx/xxxx/xxxx_x_097.xxx

XXXXXXX

1)&xxxx;&xxxx;&xxxx;

Xxxxxxx II xx xxxx xxxxx:

x)

xxxxxxxx xx xxxx xxxxxxx, které xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Chemický xxxxx/XXX

Xxxxx XXX

Xxxxx XX

x

x

x

x

„1385

Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX)

51229-78-8

426-020-3

1386

Xxx-1-(3-xxxxxxxxxx)-3,5,7-xxxxxx-1-xxxxxxxxxxxxxxx-xxxxxxx (xxx-XXXX), quaternium-15

51229-78-8

426-020-3

1387

2-Chloracetamid

79-07-2

201-174-2

1388

Oktamethylcyklotetrasiloxan

556-67-2

209-136-7

1389

Dichlormethan; xxxxxxxxxxxxxxx

75-09-2

200-838-9

1390

2,2′-((3,3′,5,5′-xxxxxxxxxxx-(1,1′-xxxxxxx)-4,4′-xxxx)-xxx(xxxxxxxxxxx))-xxxxxxxxx

85954-11-6

413-900-7

1391

Xxxxxxxxxxx; xxxxxxx

75-07-0

200-836-8

1392

1-Xxxxxxxxxxx-6,7-xxxxxxx-4-xxx-1,4-xxxxxxxxxxxxxxx-3-xxxxxxxxxxx xxxxxxxx

93107-30-3

413-760-7

1393

X-xxxxxx-2-xxxxxxxxxx; 1-xxxxxxxxxxxxxxxx-2-xx

872-50-4

212-828-1

1394

Xxxxxxxxxxxx; xxxx xxxxxx

1303-86-2

215-125-8

1395

Xxxxxxxx xxxxxx [1]

Kyselina boritá [2]

10043-35-3 [1]

11113-50-1 [2]

233-139-2 [1]

234-343-4 [2]

1396

Xxxxxxxx, xxxxxxxxxxxxx, xxxxxxxxxxxx a xxxx x xxxxxx xxxxxxxx xxxxxx, xxxxxx:

Xxxxxxxxxxx disodný xxxxxxxxxxx [1]

12280-03-4 [1]

234-541-0 [1]

2-xxxxxxxxxxxx, xxxxxxxxx x xxxxxxxxx boritou [2]

10377-81-8 [2]

233-829-3 [2]

(2-xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxxxxxxx [3]

68003-13-4 [3]

268-109-8 [3]

Xxxxxxx draselný, xxxxxxxx xxx xxxxxxxx xxxxxx [4]

12712-38-8 [4]

603-184-6 [4]

Xxxxxxxxxxxxxxx-xxxxx [5]

-[5]

— [5]

Xxxxxxx xxxxxxxxx [6]

1332-07-6 [6]

215-566-6 [6]

Xxxxxxx xxxxx, tetraboritan xxxxxxx xxxxxxx; xxxxx xxx xxxxxxxx xxxxxx [7]

1330-43-4 [7]

215-540-4 [7]

Xxxxxxxxx xxxxxxx-xxxxxxxxxxx xxxxxx [8]

12267-73-1 [8]

235-541-3 [8]

Xxxxx xxx xxxxxxxx orthoborité [9]

13840-56-7 [9]

237-560-2 [9]

Tetraboritan xxxxxxx xxxxxxxxxx; xxxxx xxxxxxxxxx [10]

1303-96-4 [10]

215-540-4 [10]

Xxxxxxxxxxxx xxxxxxx xxxxxxxxxxx; borax xxxxxxxxxxx [11]

12179-04-3 [11]

215-540-4 [11]

1397

Xxxxxxxxxx xxxxx [1]

xxxxxxxxxxxxxxxxx xxxxx; peroxoboritan xxxxx [2]

15120-21-5 [1]

239-172-9 [1]

7632-04-4 [2]

10332-33-9 [2]

10486-00-7[2]

231-556-4 [2]

1398

Xxxxxxxx xxxxxxxxx (X3XX2(X2)), monosodná xxx, trihydrát [1]

13517-20-9 [1]

239-172-9 [1]

kyselina xxxxxxxxx, xxxxx sůl, xxxxxxxxxxx [2]

37244-98-7 [2]

234-390-0 [2]

xxxxxxxx xxxxxxxxx (HBO(O2)), sodná xxx, xxxxxxxxxxx xxxxxxxxxxxxx xxxxx hexahydrát [3]

10486-00-7 [3]

231-556-4 [3]

1399

Kyselina perboritá, xxxxx xxx [1]

11138-47-9 [1]

234-390-0 [1]

xxxxxxxx xxxxxxxxx, xxxxx sůl, monohydrát [2]

12040-72-1 [2]

234-390-0 [2]

xxxxxxxx xxxxxxxxx (XXX(X2)), xxxxx xxx, monohydrát [3]

10332-33-9 [3]

231-556-4 [3]

1400

Xxxxxxxxxx-xxxxxxxxxxxxx

75113-37-0

401-040-5

1401

Xxxxxxxxxxxxxxxxxx nikelnatý

14708-14-6

238-753-4

1402

Mankozeb (XXX); xxxxxx-X,X′-xxxxxxxxxx(xxxxxxxxxxxxxx), xxxxxxxxx xxxxxxx xx xxxxxxxxxx xxxx

8018-01-7

616-995-5

1403

Xxxxx (ISO); xxxxxx-X,X′-xxxxxxxxxx(xxxxxxxxxxxxxx) (xxxxxxxxx)

12427-38-2

235-654-8

1404

Xxxxxxxxxxx (XXX); xxxxx-X-[({[(2,2-xxxxxxxx-2,3-xxxxxxx-1-xxxxxxxxxx-7-xx)xxx]xxxxxxxx} xxxxxxxxxxx)xxxxxxxx]-X-xxxxxxxxx-β-xxxxxxxx

82560-54-1

617-356-3

1405

X-xxxxxxxx-X-xxxxxx xxxxxxxxxxxxxxxxxxxx

103122-66-3

434-350-4

1406

Xxxxxxxxxxx (ISO); xxxxxxxxx-3-xxxxxxxxxxxxxxx

101-21-3

202-925-7

1407

Xxxxx-X-(xxxxxxxxxxxxxx)xxxxxxxxxxxx

109202-58-6

432-750-3

1408

Xxxxxxxxxxxxxxx-xxxxxx

13465-08-2

236-691-2

1409

(4-Xxxxxxxxxxx)[3-(3-xxxxxx-4-xxxxxxxxxx)xxxxxx]xxxxxxxxxxxxx

105024-66-6

405-020-7

1410

Xxxxx (XXX); xxxxxxx-X-[xxxxx(xxxx)xxxxxx]xxxxxxxxxxxx

14816-18-3

238-887-3

1411

Xxxxxxxxxx xxxxxx (XXX); amonium-2-amino-4-[hydroxy (xxxxxx)xxxxxxxx]xxxxxxxx

77182-82-2

278-636-5

1412

Xxxxxxx směs: xxxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx; xxxxx-xxxxxx-{2-[X-(xxxxxxxxxxxxx)xxxxxxxxx]xxxxx}xxxxxxxx

—

435-960-3

1413

(4-Xxxxxxxxxx)xxxxxxxxx xxxxxxxx

86552-32-1

420-450-5

1414

Xxxxxxx xxxx: 4,7-bis(merkaptomethyl)-3,6,9-trithia-1,11-undekandithiol; 4,8-bis(merkaptomethyl)-3,6,9-trithia-1,11-undekandithiol; 5,7-xxx(xxxxxxxxxxxxxx)-3,6,9-xxxxxxx-1,11-xxxxxxxxxxxxxx

170016-25-8

427-050-1

1415

Xxxxxxxxxxx xxxxxxxxxx-xxxxxxxxxxxxxx(X2Xx6X13)

12056-51-8

432-240-0

1416

Xxxxx xxxxxxxxxx

71-48-7

200-755-8

1417

Xxxxxxxx xxxxxxxxxx

10141-05-6

233-402-1

1418

Xxxxxxxxx xxxxxxxxxx

513-79-1

208-169-4

1419

Xxxxxxx nikelnatý

7718-54-9

231-743-0

1420

Dusičnan xxxxxxxxx [1]

13138-45-9 [1]

236-068-5 [1]

xxxxxxxx xxxxxxx, xxx xxxxx [2]

14216-75-2 [2]

238-076-4 [2]

1421

Xxxxxxx xxxxxxx (lech)

69012-50-6

273-749-6

1422

Bahna x kaly x xxxxxxxxxxxxxx rafinace mědi, xxxxxxx xxxx, x xxxxxxx xxxxxx xxxxxxxxxxx

92129-57-2

295-859-3

1423

Xxxxx x kaly x xxxxxxxxxxxxxx xxxxxxxx mědi, xxxxxxx xxxx

94551-87-8

305-433-1

1424

Xxxxxxxxxx xxxxxxxxx; xxxxxxxx xxxxxxxxx, xxxxxxxxx xxx

13637-71-3

237-124-1

1425

Xxxxx didraselno-nikelnatý [1]

13842-46-1 [1]

237-563-9 [1]

xxxxx diamonno-nikelnatý [2]

15699-18-0 [2]

239-793-2 [2]

1426

Xxxx-xxx(xxxxxxxxxx); xxxx-xxxxxxxx

13770-89-3

237-396-1

1427

Xxxxxxxxxxxxxxxxxx nikelnatý

14708-14-6

238-753-4

1428

Nikl-diformiát [1]

3349-06-2 [1]

222-101-0 [1]

mravenčí xxxxxxxx, xxx niklu [2]

15843-02-4 [2]

239-946-6 [2]

xxxxxxxx xxxxxxxx, xxx xxxx a xxxxx [3]

68134-59-8 [3]

268-755-0 [3]

1429

Xxxx-xxxxxxxx [1]

373-02-4 [1]

206-761-7 [1]

xxxx-xxxxxx [2]

14998-37-9 [2]

239-086-1 [2]

1430

Xxxx(XX)-xxxxxxxxx

553-71-9

209-046-8

1431

Xxxx-xxx(4-xxxxxxxxxxxxxxxxxx)

3906-55-6

223-463-2

1432

Xxxx(XX)-xxxxxxx; xxxx(XX)-xxxxxxx

2223-95-2

218-744-1

1433

Xxxx-xxxxxxxx

16039-61-5

—

1434

Xxxx(XX)-xxxxxxxx

4995-91-9

225-656-7

1435

Xxxxxxx xxxxxxxxx [1]

10028-18-9 [1]

233-071-3 [1]

xxxxxx xxxxxxxxx [2]

13462-88-9 [2]

236-665-0 [2]

xxxxx xxxxxxxxx [3]

13462-90-3 [3]

236-666-6 [3]

xxxxxxx xxxxxxxx-xxxxxxxxx [4]

11132-10-8 [4]

- [4]

1436

Hexafluorokřemičitan xxxxxxxxx

26043-11-8

247-430-7

1437

Xxxxxxx xxxxxxxxx

15060-62-5

239-125-2

1438

Xxxxxxxxxxxxxxxxxxx xxxxxxxxx [1]

14332-34-4 [1]

238-278-2 [1]

xxx(xxxxxxxxxxxxxxxxxxxxx) xxxxxxxxx [2]

18718-11-1 [2]

242-522-3 [2]

xxxxxxxxxxxxxxxx xxxxxxxxx [3]

10381-36-9 [3]

233-844-5 [3]

difosforečnan dinikelnatý [4]

14448-18-1 [4]

238-426-6 [4]

xxx(xxxxxxxxx) xxxxxxxxx [5]

14507-36-9 [5]

238-511-8 [5]

xxxxxxxxxxxx xxxxx [6]

36026-88-7 [6]

252-840-4 [6]

xxxxxxxx xxxxxxxxxx, xxx xxxxxxx x xxxxx [7]

17169-61-8 [7]

- [7]

xxxxxxxx difosforečná, nikelnatá xxx [8]

19372-20-4 [8]

— [8]

1439

Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx-xxxxxxxxx

74195-78-1

—

1440

Xxxxxx xxxxxxxxx

557-19-7

209-160-8

1441

Xxxxxxx xxxxxxxxx

14721-18-7

238-766-5

1442

Xxxxxxxxxx nikelnatý [1]

21784-78-1 [1]

244-578-4 [1]

xxxxxxxxxxxxxxx xxxxxxxxxxx [2]

13775-54-7 [2]

237-411-1 [2]

křemičitan xxxxxxxxx (3:4) [3]

31748-25-1 [3]

250-788-7 [3]

kyselina xxxxxxxxx, xxx xxxxx [4]

37321-15-6 [4]

253-461-7 [4]

xxxxxxxxxxx-xxxxxxxxxx [orthosilikato(4-)]trinikelnatá(3-)kyselina [5]

12519-85-6 [5]

235-688-3 [5]

1443

Hexakyanidoželeznatan xxxxxxxxxxx

14874-78-3

238-946-3

1444

Xxxxxxxxxxxxx trinikelnatý; arseničnan xxxxxxxxx

13477-70-8

236-771-7

1445

Xxxx(XX)-xxxxxx [1]

547-67-1 [1]

208-933-7 [1]

xxxxxxxxx kyselina, sůl xxxxx [2]

20543-06-0 [2]

243-867-2 [2]

1446

Xxxxxxxx nikelnatý

12142-88-0

235-260-6

1447

Tetrasulfid triniklu

12137-12-1

—

1448

Bisarsenitan xxxxxxxxxxxx

74646-29-0

—

1449

Xxxx periklas x xxxxxxx niklu x xxxxxxx; X.X. pigmentová xxxx 25; C.I. 77332 [1]

68186-89-0 [1]

269-051-6 [1]

xxxxxx xxxxxxxxxx-xxxxxxxxx [2]

58591-45-0 [2]

261-346-8 [2]

xxxx xxxxxxx x xxxxx [3]

12737-30-3 [3]

620-395-9 [3]

1450

Xxxxxxx xxxxxxxxx-xxxxxxxx; xxxxxxxxx xxxxxxxxx

12035-38-0

234-824-9

1451

Xxxxxxxx xxxxxxxxx-xxxxxxxxxx

15780-33-3

239-876-6

1452

Xxxxxxxxxxxxxx xxxxxxxxx

13689-92-4

237-205-1

1453

Xxxxxxxxx xxxxxxxxx

15586-38-6

239-646-5

1454

Xxxxxxxxxxx xxxxxxxxx

10101-96-9

233-263-7

1455

Xxxxxxx xxxxxxxxx

1314-05-2

215-216-2

1456

Xxxxxxxx xxxxxxxxx, xxx xxxxx a xxxxx

68130-19-8

—

1457

Xxxxxxxxx xxxxx [1]

12068-61-0 [1]

235-103-1 [1]

xxxxxxx xxxxx [2]

27016-75-7 [2]

248-169-1 [2]

1458

Světle žlutý xxxxxxxx s xxxxxxx xxxxx, xxxxx x xxxxxx; X.X. pigmentová xxxx 157; X.X. 77900

68610-24-2

271-853-6

1459

Xxxxxxxxxx xxxxxxxxx [1]

67952-43-6 [1]

267-897-0 [1]

bromičnan nikelnatý [2]

14550-87-9 [2]

238-596-1 [2]

xxxxx-xxxxxxxx-xxxxxx, xxxxxxxxx xxx [3]

71720-48-4 [3]

275-897-7 [3]

1460

Nikl(II)-trifluoracetát [1]

16083-14-0 [1]

240-235-8 [1]

nikl(II)-propionát [2]

3349-08-4 [2]

222-102-6 [2]

xxxx-xxx(xxxxxxxxxxxxxx) [3]

39819-65-3 [3]

254-642-3 [3]

xxxx(XX)-xxxxxxxx-xxxxxx [4]

18721-51-2 [4]

242-533-3 [4]

citronová kyselina, xxxxxxxxxxxxxxx xxx [5]

18283-82-4 [5]

242-161-1 [5]

xxxxxxxxx kyselina, xxx niklu [6]

22605-92-1 [6]

245-119-0 [6]

xxxx-[xxx(2-xxxxxxxxxxxxx)] [7]

4454-16-4 [7]

224-699-9 [7]

2-xxxxxxxxxxxxx xxxxxxxx, xxx xxxxx [8]

7580-31-6 [8]

231-480-1 [8]

xxxxxxxxxxxxxxxx xxxxxxxx, xxx xxxxx [9]

93983-68-7 [9]

301-323-2 [9]

xxxx(XX)-xxxxxxxxxxx [10]

29317-63-3 [10]

249-555-2 [10]

xxxxxxxxxxx kyselina, xxx xxxxx [11]

27637-46-3 [11]

248-585-3 [11]

xxxx-xxxxxxxxxxxxx [12]

84852-37-9 [12]

284-349-6 [12]

xxxx(XX)-xxxxxxxxxxx [13]

93920-10-6 [13]

300-094-6 [13]

xxxx(XX)-xxxxxxxxxxx [14]

85508-43-6 [14]

287-468-1 [14]

nikl(II)-neodekanoát [15]

85508-44-7 [15]

287-469-7 [15]

xxxxxxxxxxx kyselina, xxx xxxxx [16]

51818-56-5 [16]

257-447-1 [16]

xxxx(XX)-xxxxxxxxxxxxx [17]

93920-09-3 [17]

300-093-0 [17]

xxx(X-xxxxxxxxx-X 1,X 2)xxxx [18]

71957-07-8 [18]

276-205-6 [18]

xxxx-xxx(3,5-xx-xxxx-xxxxx-4-xxxxxxxxxxxxxx (1:2) [19]

52625-25-9 [19]

258-051-1 [19]

nikl(II)-palmitát [20]

13654-40-5 [20]

237-138-8 [20]

(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [21]

85508-45-8 [21]

287-470-2 [21]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [22]

85508-46-9 [22]

287-471-8 [22]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [23]

84852-35-7 [23]

284-347-5 [23]

(2-ethylhexanoato-O)(isodekanoato-O)nikl [24]

84852-39-1 [24]

284-351-7 [24]

(2-xxxxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [25]

85135-77-9 [25]

285-698-7 [25]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [26]

85166-19-4 [26]

285-909-2 [26]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [27]

84852-36-8 [27]

284-348-0 [27]

(xxxxxxxxxxxx-X)(xxxxxxxxxxxx-X)xxxx [28]

85551-28-6 [28]

287-592-6 [28]

mastné kyseliny, X6-19 rozvětvené, soli xxxxx [29]

91697-41-5 [29]

294-302-1 [29]

xxxxxx xxxxxxxx, X8-18 x nenasycené X18, xxxx xxxxx [30]

84776-45-4 [30]

283-972-0 [30]

xxxxxxxx-2,7-xxxxxxxxxxx xxxxxxxx, xxxxxxxxx xxx [31]

72319-19-8 [31]

[31]

1461

Xxxxxxxxx nikelnatý [1]

7757-95-1 [1]

231-827-7 [1]

xxxxxxx nikelnato-telluričitý [2]

15851-52-2 [2]

239-967-0 [2]

tetraoxid xxxxxxxxx-xxxxxxxxx [3]

15852-21-8 [3]

239-974-9 [3]

xxxxxxxxxxx-xxxxxxxx-xxxx molybdenu x xxxxx [4]

68130-36-9 [4]

268-585-7 [4]

1462

Xxxxx xxxxx (XxX) [1]

12007-00-0 [1]

234-493-0 [1]

borid xxxxxxx [2]

12007-01-1 [2]

234-494-6 [2]

xxxxx triniklu [3]

12007-02-2 [3]

234-495-1 [3]

xxxxx niklu [4]

12619-90-8 [4]

235-723-2 [4]

xxxxxxx xxxxxxxxx [5]

12059-14-2 [5]

235-033-1 [5]

xxxxxxxxx xxxxx [6]

12201-89-7 [6]

235-379-3 [6]

xxxxxx xxxxxxx [7]

12035-64-2 [7]

234-828-0 [7]

xxxxxx xxxxx a xxxx [8]

65229-23-4 [8]

[8]

1463

Tetraoxid xxxxxxxxx-xxxxxxxxx [1]

12004-35-2 [1]

234-454-8 [1]

xxxxxxx xxxxxxxxx-xxxxxxxxxx [2]

12035-39-1 [2]

234-825-4 [2]

xxxx niklu x xxxxxx [3]

12653-76-8 [3]

235-752-0 [3]

xxxxxxxx xxxxxxxxx-xxxxxxxxxxx [4]

52502-12-2 [4]

257-970-5 [4]

xxxxxxxx xxxxxxxxxx-xxxxxxxxx-xxxxxxxxxxxxx [5]

68016-03-5 [5]

268-169-5 [5]

xxxxxxx xxxxxxxxx-xxxxxxxxxxx [6]

70692-93-2 [6]

274-755-1 [6]

xxxxxxxxx xxxxxxxxx-xxxxxxxxxxx [7]

14177-55-0 [7]

238-034-5 [7]

tetraoxid nikelnato-wolframový [8]

14177-51-6 [8]

238-032-4 [8]

olivín, xxxxxxx zeleň [9]

68515-84-4 [9]

271-112-7 [9]

xxxxxx dilithno-nikelnatý [10]

12031-65-1 [10]

620-400-4 [10]

xxxx xxxxxxxxx x niklu [11]

12673-58-4 [11]

— [11]

1464

Xxxxxx-xxxxxxx-xxxx-xxxx

—

442-750-5

1465

Xxxx xxxxxxxxxxx

1313-27-5

215-204-7

1466

Xxxxxxxxxxxxxxxxxxx (XXXX)

683-18-1

211-670-0

1467

4,4′-xxx(X-xxxxxxxxx-4-xxxxxxxxxxxxxxxxxxxxxx) difenylmethan

151882-81-4

418-770-5

1468

Furfurylalkohol; (2-xxxxx)xxxxxxxx

98-00-0

202-626-1

1469

1,2-Xxxxx-4-(1,2-xxxxxxxxxx)xxxxxxxxxx; 4-xxxxxxxxxxxxxxxxxxxxxxx

106-87-6

203-437-7

1470

6-Xxxxxxxxxxxxxxx-1-xx-xxxxxxxxxxxxxxx

27610-48-6

429-960-2

1471

2-(2-Xxxxxxxxxxxxxxx)xxxxxxx (AEEA)

111-41-1

203-867-5

1472

1,2-Diethoxyethan

629-14-1

211-076-1

1473

(2,3-Epoxypropyl)trimethylamonium-chlorid; xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

3033-77-0

221-221-0

1474

1-(2-Xxxxx-5-xxxxxxxxxx)-2,2,2-xxxxxxxxxxxxx-1,1-xxxx-xxxxxxxxxxxx

214353-17-0

433-580-2

1475

(X)-3-[1-[4-[2-(xxxxxxxxxxxxx)xxxxxx]xxxxx]-2-xxxxxxxx-1-xxxx]xxxxx

82413-20-5

428-010-4

1476

4,4′-[1,3-Xxxxxxxxxx(1-xxxxxxxxxxxxx)]xxxxxxx

13595-25-0

428-970-4

1477

2-Xxxxx-6-xxxxxxxxxx

2040-90-6

433-890-8

1478

5-Xxxx-xxxxx-2-xxxxxxxxxxxx-1-xxxxx

—

444-970-7

1479

2-Xxxxxxx-3-xxxxxxx-5-xxxxxxxxxxxxxx-3-xx-xxxxxxxx-2-xx-1-xx

94723-86-1

425-150-8

1480

Xxxxxxxxxx (ISO); 2-{(EZ)-1-[(2RS)-2-(4-chlorfhenoxy) xxxxxxxxxxxx]xxxxx}-3-xxxxxxx-5-(xxxxx-3-xx)xxxxxxxx-2-xx-1-xx

139001-49-3

604-105-8

1481

Xxxxxxxxxxxx (ISO); (RS)-(EZ)-2-{1-[(2E)-3-chlorallyloxyimino]propyl}-3-hydroxy-5-perhydropyran-4-ylcyklohex-2-en-1-on

149979-41-9

604-715-4

1482

3,3-(Ethylendioxy)estra-5(10),9(11)-dien-17-on

5571-36-8

427-230-8

1483

Androsta-1,4,9(11)-trien-3,17-dion

15375-21-0

433-560-3

1484

Reakční xxxx: kalcium-alkylsalicyláty (rozvětvené xxxxxx C10-C14 x X18-X30); kalcium-alkylfenoláty (rozvětvené xxxxxx X10-X14 x X18-X30); xxxxxxx-xxxxxxxxxxxxxxxxxxx (xxxxxxxxxx xxxxxx X10-X14 x X18-X30)

—

415-930-6

1485

Xxxxxxxx 1,2-xxxxxxxxxxxxxxxxxxx; xxxxxxx-(xxxxxx X6-X8)xxxxxx, xxxxxxxxxx, bohaté xx C7

71888-89-6

276-158-1

1486

Reakční směs: xxxxxxx 4,4′-xxxxxxxxxxxx[2-(2-xxxxxxx-5-xxxxxxxxxxxx)-3,6-xxxxxxxxxxxxxx] x xxxxxxxx 6-diazo-5,6-dihydro-5-oxonaftalen-1-sulfonové (1:2); xxxxxxxx 4,4′-methylenbis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylfenolu] x xxxxxxxx 6-diazo-5,6-dihydro-5-oxonaftalen-1-sulfonové (1:3)

—

427-140-9

1487

Xxxxxxxxx 1-xxxxxxx-2-(4-(4-xxxxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx)-7-xxxxx-3-xxxxxxxxxxxxxxxx

150202-11-2

422-670-7

1488

Xxxxxxxx 3-oxoandrost-4-en-17-β -karboxylová

302-97-6

414-990-0

1489

Kyselina (X)-2-xxxxxxxxxxx-2-[2-(xxxxxxxxxxx)xxxxxxx-4-xx]xxxxxx

64485-90-1

431-520-1

1490

Xxxxxxxxxx-xxxxxxxxxxxxxxxx

5064-31-3

225-768-6

1491

2-Xxxxxxxxxx-(2-xxxxxxxxxxxxx)

7425-14-1

231-057-1

1492

Xxxxxxxxxx-xxxxxx

84-69-5

201-553-2

1493

Xxxxxxxxxxxxxxxxxxxxxx kyselina; xxxxxxxxxxxxxxxxxxx-1-xxxxxxxxx xxxxxxxx [1]

1763-23-1 [1]

217-179-8 [1]

xxxxxx-xxxxxxxxxxxxxxxxxxxxx; kalium-heptadekafluoroktan-1-sulfonát [2]

2795-39-3 [2]

220-527-1 [2]

xxxxxxxxxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]

70225-14-8 [3]

274-460-8 [3]

amonium-perfluoroktansulfonát; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [4]

29081-56-9 [4]

249-415-0 [4]

xxxxxxx-xxxxxxxxxxxxxxxxxxxxx; xxxxxxx-xxxxxxxxxxxxxxxxxxxxxxxxxxx [5]

29457-72-5 [5]

249-644-6 [5]

1494

Xxxxx-[1-(2,4-xxxxxxxxxxxx)5-(xxxxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-3-xxxxxxxxxx]

103112-35-2

401-290-5

1495

1-Xxxx-2-xxxxxxxxxxxxxxxxxxxxx

158894-67-8

422-900-6

1496

1-Xxxxxxxxxxxxxxx-xxxxxxxxxxxxx

99464-83-2

444-950-8

1497

6,6′-Xxx(xxxxx-5,5′,6,6′-xxxxxxxxxx-5,5′-xxxxx)[xxxxxxxxxxx(5-(6-xxxxx-5,6-xxxxxxx-5-xxx-1-xxxxxxxxxxxxxxxxx)-6-xxxxxx-2-xxxxxxx]xx(xxxxxxxx-1-xxxxxxxx)

—

441-550-5

1498

Xxxxxxxxxxx (XXX); α,α,α-xxxxxxxxx-2,6-xxxxxxx-X,X-xxxxxxxx-x-xxxxxxxx; 2,6-xxxxxxx-X,X-xxxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx; X,X-xxxxxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxxx

1582-09-8

216-428-8

1499

4-Xxxxx-2-xxxxxxxxxxx

1671-49-4

430-550-0

1500

Xxxxxxxxxx-4-[(4-[1-xxxxxxx-7-(4-xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxx-2-xxxxxx]xxx-2,5-xxxxxxxxxxxxxx)xxx]xxxxxxx

221354-37-6

432-270-4

1501

Xxxxxxx xxxx: xxxxxxxxxx-6-xxxxx-3-({2,5-xxxxxxxx-4-[(3-xxxxxxxxxxxx)xxx]xxxxx}xxx)-4-xxxxxxxxxxxxxxx-2-xxxxxxxx; xxxxxxxxx-3-({4-[(7-xxxxx-1-xxxxxxx-3-xxxxx-2-xxxxxx)xxx]-2,5-xxxxxxxxxxxxx}xxx)xxxxxxx

163879-69-4

438-310-7

1502

X,X′-(xxxxxxx-4,4′-xxxx)xxxxxxxxxxx

613-35-4

210-338-2

1503

Xxxxxxxxxxxxxx

108-91-8

203-629-0

1504

Xxxxxxxxx

110-85-0

203-808-3

1505

Xxxxxxxxxxxx

7803-49-8

232-259-2

1506

Xxxxxxxxxxxxxxx-xxxxxxx; xxxxxxxxxxxx-xxxxxxxxxxxx [1]

5470-11-1 [1]

226-798-2 [1]

bis(hydroxylamonium-sulfát); xxxxxxxxxxxx-xxxxxx (2:1) [2]

10039-54-0 [2]

233-118-8 [2]

1507

Xxxxxxxxxxxxxxxxxxx; xxxxxxxxxxxxx

—

—

1508

Xxxxxxxxxxx; 4-xxxxxx-X-xxxxx-6-(1-xxxxxxxx)-2-xxxxxxxxxxxxx

110235-47-7

600-951-7

1509

Xxxxxxxxxxxxxxx-xxxxxxxxxxxxxx; xxxxxxxxxxxx-xxxxxx (1:1) [1]

10046-00-1 [1]

233-154-4 [1]

hydroxylamin-fosfát [2]

20845-01-6 [2]

244-077-0 [2]

xxxxxxxxxxxx-xxxxxxxxxxxxxxxx [3]

19098-16-9 [3]

242-818-2 [3]

xxxxxxxxxxxx-4-xxxxxxxxxxxx-1-xxxxxxxx [4]

53933-48-5 [4]

258-872-5 [4]

1510

(3-Chlor-2-hydroxypropyl)trimethylamonium-chlorid

3327-22-8

222-048-3

1511

Bifenyl-3,3′,4,4′-tetramin; 3,3′-xxxxxxxxxxxxxxx

91-95-2

202-110-6

1512

Xxxxxxxxx-xxxxxxxxxxxx [1]

6094-40-2 [1]

228-042-7 [1]

xxxxxxxxx-xxxxxxxxxxxxxx [2]

142-64-3 [2]

205-551-2 [2]

xxxxxxxxx-xxxxxx [3]

1951-97-9 [3]

217-775-8 [3]

1513

3-(Xxxxxxxxx-1-xx)-xxxxx[x]xxxxxxxxxx-xxxxxxxxxxxx

87691-88-1

421-310-6

1514

(2-Xxxxxxxxxx)xxxxxxxx-xxxxxxxxxxxx

19398-06-2

421-460-2

1515

(2-Xxxxxxxxxx)(3-xxxxxxxxxxxxx)xxxxxxx-xxxxxxx

40722-80-3

429-740-6

1516

4-[(3-Xxxxxxxxxx)(xxxxxxxx-1-xx)xxxxxx]xxxxxx-1,2-xxxxxxxxxxxxxxxxxxxx

159939-85-2

425-030-5

1517

Xxxxx-X,X-xxxxxxxxxxxxxxxxxxx-xxxxxxx

3724-43-4

425-970-6

1518

7-Xxxxxxx-6-[3-(xxxxxxxx-4-xx)xxxxxxx]xxxxxxxxxx-4(3X)-xx;

199327-61-2

429-400-7

1519

Xxxxxxxx xxxxxx xxx(2-xxxxxxxxxxxxx) xxxxx x xxxxxxxxxxxxx (1:4)

220444-73-5

432-440-8

1520

3-Xxxxx-4-[(3-xxxxxxxxxxx)xxx]xxxxxx

202197-26-0

445-590-4

1521

Xxxxxxxxxxxxxx; 3,8-Xxxxxxx-1-xxxxx-6-xxxxxxxxxxxxxxxxxxxx-xxxxxx

1239-45-8

214-984-6

1522

(2XX)-2-xxxxx-3,3-xxxxxxxxxxxxxxxxx

144177-62-8

447-860-7

1523

9-Xxxxxxxxxxxxx-3-xxxx; (9-Ethylkarbazol-3-yl)amin

132-32-1

205-057-7

1524

(6R-trans)-1-((7-amonio-2-karboxylato-8-oxo-5-thia-1-azabicyklo-[4.2.0]okt-2-en-3-yl)methyl)pyridinium-jodid

100988-63-4

423-260-0

1525

Forchlorfenuron (XXX); 1-(2-xxxxx-4-xxxxxxx)-3-xxxxxxxxxxxxx

68157-60-8

614-346-0

1526

1,3-Xxxxxxxxxxxxxxxxxxxxxxxxxxx-2(1X)-xx; xxxxxxxxxxxxxxxxxxxxxxxx

7226-23-5

230-625-6

1527

Xxxxxxxx

91-22-5

202-051-6

1528

Xxxxxxxxxxx; 1-[4-(4-{[(2XX,4XX)-2-(2,4-xxxxxxxxxxxx)-2-(xxxxxxxx-1-xxxxxxxx)-1,3-xxxxxxxx-4-xx]xxxxxxx} xxxxx)xxxxxxxxx-1-xx]xxxxx-1-xx

65277-42-1

265-667-4

1529

Xxxxxxxxxx (ISO); (1XX,5XX;1XX,5XX)-5-(4-xxxxxxxxxxx)-2,2-xxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xxxxxxxx)xxxxxxxxxxx-1-xx

125116-23-6

603-031-3

1530

Xxxxxx-1-xxxxxx-4-{3-[1-xxxxxx-3-(xxxxxxxxxxxxxxxxx)-5-xxx-4,5-xxxxxxxxxxxxxx-4-xxxxxx]xxxx-1-xx-1-xx}-3-(xxxxxxxxxxxxxxxxx)xxxxxxx-5-xxxx

183196-57-8

418-260-2

1531

1,3,5-Xxxx(2,3-xxxxx-2-xxxxxxxxxxxx)-1,3,5-xxxxxxx-2,4,6(1X,3X,5X)-xxxxx

26157-73-3

435-010-8

1532

2,2-Xxx(xxxxxxxxxxxxx)xxxxx-1-xx-xxxx[3-(xxxxxxxx-1-xx)xxxxxxxxx]; (XXX)

52234-82-9

257-765-0

1533

4,4′-Xxxxxxxxxxxxxxx xxxxxxxxxxx; xxxxxxxxxxxxx-4,4′-xxxxxxxxxxx [1]

101-68-8 [1]

202-966-0 [1]

2,2′-xxxxxxxxxxxxxxx diisokyanát; xxxxxxxxxxxxx-2,2′-xxxxxxxxxxx [2]

2536-05-2 [2]

219-799-4 [2]

x-(x-xxxxxxxxxxxxxxxx)xxxxx xxxxxxxxx; xxxxxxxxxxxxx-2,4′-xxxxxxxxxxx [3]

5873-54-1 [3]

227-534-9 [3]

xxxxxxxxxxxxxxx-xxxxxxxxxxx [4]

26447-40-5 [4]

247-714-0 [4]

1534

Xxxxxxx ethyl (XXX); ethyl-(Z)-2-chlor-3-[2-chlor-5-(cyklohex-1-en-1,2-dikarboximido)fenyl]akrylát

142891-20-1

604-318-6

1535

N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamid

84245-12-5

424-550-1

1536

Dimoxystrobin (XXX); (X)-2-(xxxxxxxxxxxx)-X-xxxxxx-2-[α-(2,5-xxxxxxxx)-x-xxxxx]xxxxxxxx

149961-52-4

604-712-8

1537

2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxxxxxxxxxxx

27366-72-9

435-470-1

1538

Xxxxxxx xxxx: 2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx[X-(2,4-xxxxxxxxxxxxx)-3-xxxxxxxxxxxx]; X-(2,4-xxxxxxxxxxxxx)-X′-(2-xxxxxxxxxxx)-2,2′-[(3,3′-xxxxxxxxxxxxxx-4,4′-xxxx)xxxxxx]xxx(3-xxxxxxxxxxxx); 2-[[3,3′-dichlor-4′-[[1[[(2,4-dimethylfenyl)amino]karbonyl]-2-oxopropyl]azo][1,1′-bifenyl]-4-yl]azo]-N-(2-karboxylfenyl)-3-oxo-butanamid

434-330-5

1539

Ropa, uhlí, xxxxx x xxxxx xxxx a jejich xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx zpracování, xxxxx xxxxxxxx ≥ 0,1 % hmotnostních xxxxxxx

85536-20-5

85536-19-2

90641-12-6

90989-38-1

91995-20-9

92062-36-7

91995-61-8

101316-63-6

93821-38-6

90641-02-4

101316-62-5

90641-03-5

65996-79-4

101794-90-5

90640-87-2

84650-03-3

65996-82-9

90641-01-3

65996-87-4

90640-99-6

68391-11-7

92062-33-4

91082-52-9

68937-63-3

92062-28-7

92062-27-6

91082-53-0

91995-31-2

91995-35-6

91995-66-3

122070-79-5

122070-80-8

65996-78-3

94114-52-0

94114-53-1

94114-54-2

94114-56-4

94114-57-5

90641-11-5

8006-61-9

8030-30-6

8032-32-4

64741-41-9

64741-42-0

64741-46-4

64742-89-8

68410-05-9

68514-15-8

68606-11-1

68783-12-0

68921-08-4

101631-20-3

64741-64-6

64741-65-7

64741-66-8

64741-70-4

64741-84-0

64741-92-0

68410-71-9

68425-35-4

68527-27-5

91995-53-8

92045-49-3

92045-55-1

92045-58-4

92045-64-2

101316-67-0

64741-54-4

64741-55-5

68476-46-0

68783-09-5

91995-50-5

92045-50-6

92045-59-5

92128-94-4

101794-97-2

101896-28-0

64741-63-5

64741-68-0

68475-79-6

68476-47-1

68478-15-9

68513-03-1

68513-63-3

68514-79-4

68919-37-9

68955-35-1

85116-58-1

91995-18-5

93571-75-6

93572-29-3

93572-35-1

93572-36-2

64741-74-8

64741-83-9

67891-79-6

67891-80-9

68425-29-6

68475-70-7

68603-00-9

68603-01-0

68603-03-2

68955-29-3

92045-65-3

64742-48-9

64742-49-0

64742-73-0

68410-96-8

68410-97-9

68410-98-0

68512-78-7

85116-60-5

85116-61-6

92045-51-7

92045-52-8

92045-57-3

92045-61-9

92062-15-2

93165-55-0

93763-33-8

93763-34-9

64741-47-5

64741-48-6

64741-69-1

64741-78-2

64741-87-3

64742-15-0

64742-22-9

64742-23-0

64742-66-1

64742-83-2

64742-95-6

68131-49-7

68477-34-9

68477-50-9

68477-53-2

68477-55-4

68477-61-2

68477-89-4

68478-12-6

68478-16-0

68513-02-0

68516-20-1

68527-21-9

68527-22-0

68527-23-1

68527-26-4

68603-08-7

68606-10-0

68783-66-4

68919-39-1

68921-09-5

85116-59-2

86290-81-5

90989-42-7

91995-38-9

91995-41-4

91995-68-5

92045-53-9

92045-60-8

92045-62-0

92045-63-1

92201-97-3

93165-19-6

94114-03-1

95009-23-7

97926-43-7

98219-46-6

98219-47-7

101316-56-7

101316-66-9

101316-76-1

101795-01-1

102110-14-5

68476-50-6

68476-55-1

90989-39-2

287-502-5

287-500-4

292-636-2

292-694-9

295-281-1

295-551-9

295-323-9

309-868-8

298-725-2

292-625-2

309-867-2

292-626-8

266-013-0

309-971-8

292-609-5

283-483-2

266-016-7

292-624-7

266-021-4

292-622-6

269-929-9

295-548-2

293-766-2

273-077-3

295-543-5

295-541-4

293-767-8

295-292-1

295-295-8

295-329-1

310-170-0

310-171-6

266-012-5

302-688-0

302-689-6

302-690-1

302-692-2

302-693-8

292-635-7

232-349-1

232-443-2

232-453-7

265-041-0

265-042-6

265-046-8

265-192-2

270-077-5

271-025-4

271-727-0

272-186-3

272-931-2

309-945-6

265-066-7

265-067-2

265-068-8

265-073-5

265-086-6

265-095-5

270-088-5

270-349-3

271-267-0

295-315-5

295-430-0

295-436-3

295-440-5

295-446-8

309-871-4

265-055-7

265-056-2

270-686-6

272-185-8

295-311-3

295-431-6

295-441-0

295-794-0

309-974-4

309-987-5

265-065-1

265-070-9

270-660-4

270-687-1

270-794-3

270-993-5

271-008-1

271-058-4

272-895-8

273-271-8

285-509-8

295-279-0

297-401-8

297-458-9

297-465-7

297-466-2

265-075-6

265-085-0

267-563-4

267-565-5

270-344-6

270-658-3

271-631-9

271-632-4

271-634-5

273-266-0

295-447-3

265-150-3

265-151-9

265-178-6

270-092-7

270-093-2

270-094-8

270-988-8

285-511-9

285-512-4

295-432-1

295-433-7

295-438-4

295-443-1

295-529-9

296-942-7

297-852-0

297-853-6

265-047-3

265-048-9

265-071-4

265-079-8

265-089-2

265-115-2

265-122-0

265-123-6

265-170-2

265-187-5

265-199-0

268-618-5

270-725-7

270-735-1

270-736-7

270-738-8

270-741-4

270-771-8

270-791-7

270-795-9

270-991-4

271-138-9

271-262-3

271-263-9

271-264-4

271-266-5

271-635-0

271-726-5

272-206-0

272-896-3

272-932-8

285-510-3

289-220-8

292-698-0

295-298-4

295-302-4

295-331-2

295-434-2

295-442-6

295-444-7

295-445-2

296-028-8

296-903-4

302-639-3

305-750-5

308-261-5

308-713-1

308-714-7

309-862-5

309-870-9

309-879-8

309-976-5

310-012-0

270-690-8

270-695-5

292-695-4

1540

Xxxx, xxxx, dehet x zemní xxxx x xxxxxx deriváty xxxxxxxxxx xx použití xxxxxxxxx x/xxxx jiných xxxxx xxxxxxxxxx, pokud xxxxxxxx ≥ 0,005 % hmotnostních xxxxx[x]xxxxxx

90640-85-0

92061-93-3

90640-84-9

61789-28-4

70321-79-8

122384-77-4

70321-80-1

292-606-9

295-506-3

292-605-3

263-047-8

274-565-9

310-189-4

274-566-4

1541

Xxxx, xxxx, dehet x xxxxx xxxx x xxxxxx xxxxxxxx xxxxxxxxxx xx xxxxxxx xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxxxxx xxxx xxxxx xxxxxxxx ≥ 0,005 % xxxxxxxxxxxx xxxxx[x]xxxxxx

85029-51-2

84650-04-4

84989-09-3

91995-49-2

121620-47-1

121620-48-2

90640-90-7

90641-04-6

101896-27-9

101794-91-6

91995-48-1

90641-05-7

84989-12-8

121620-46-0

90640-81-6

90640-82-7

92061-92-2

91995-15-2

91995-16-3

91995-17-4

101316-87-4

122384-78-5

84988-93-2

90640-88-3

65996-83-0

90640-89-4

90641-06-8

65996-85-2

101316-86-3

92062-22-1

96690-55-0

84989-04-8

84989-05-9

84989-06-0

84989-03-7

84989-07-1

68477-23-6

68555-24-8

91079-47-9

92062-26-5

94114-29-1

90641-00-2

68513-87-1

70321-67-4

92062-29-8

100801-63-6

100801-65-8

100801-66-9

73665-18-6

68815-21-4

65996-86-3

65996-84-1

285-076-5

283-484-8

284-898-1

295-310-8

310-166-9

310-167-4

292-612-1

292-627-3

309-985-4

309-972-3

295-309-2

292-628-9

284-901-6

310-165-3

292-603-2

292-604-8

295-505-8

295-275-9

295-276-4

295-278-5

309-889-2

310-191-5

284-881-9

292-610-0

266-017-2

292-611-6

292-629-4

266-019-3

309-888-7

295-536-7

306-251-5

284-892-9

284-893-4

284-895-5

284-891-3

284-896-0

270-713-1

271-418-0

293-435-2

295-540-9

302-662-9

292-623-1

271-020-7

274-560-1

295-544-0

309-745-9

309-748-5

309-749-0

277-567-8

272-361-4

266-020-9

266-018-8

1542

Xxxx, uhlí, xxxxx x zemní xxxx x jejich xxxxxxxx xxxxxxxxxx xx použití xxxxxxxxx x/xxxx xxxxxx xxxxx xxxxxxxxxx, xxxxx xxxxxxxx ≥ 0,1 % xxxxxxxxxxxx xxxx-1,3-xxxxx

68607-11-4

68783-06-2

68814-67-5

68814-90-4

68911-58-0

68911-59-1

68919-01-7

68919-02-8

68919-03-9

68919-04-0

68919-07-3

68919-08-4

68919-11-9

68919-12-0

68952-79-4

68952-80-7

68955-33-9

68989-88-8

92045-15-3

92045-16-4

92045-17-5

92045-18-6

92045-19-7

92045-20-0

68131-75-9

68307-98-2

68307-99-3

68308-00-9

68308-01-0

68308-10-1

68308-03-2

68308-04-3

68308-05-4

68308-06-5

68308-07-6

68308-09-8

68308-11-2

68308-12-3

68409-99-4

68475-57-0

68475-58-1

68475-59-2

68475-60-5

68476-26-6

68476-29-9

68476-40-4

68476-42-6

68476-49-3

68476-85-7

68476-86-8

68477-33-8

68477-35-0

68477-69-0

68477-70-3

68477-71-4

68477-72-5

68308-08-7

271-750-6

272-182-1

272-338-9

272-343-6

272-775-5

272-776-0

272-873-8

272-874-3

272-875-9

272-876-4

272-880-6

272-881-1

272-884-8

272-885-3

273-173-5

273-174-0

273-269-7

273-563-5

295-397-2

295-398-8

295-399-3

295-400-7

295-401-2

295-402-8

268-629-5

269-617-2

269-618-8

269-619-3

269-620-9

269-630-3

269-623-5

269-624-0

269-625-6

269-626-1

269-627-7

269-629-8

269-631-9

269-632-4

270-071-2

270-651-5

270-652-0

270-653-6

270-654-1

270-667-2

270-670-9

270-681-9

270-682-4

270-689-2

270-704-2

270-705-8

270-724-1

270-726-2

270-750-3

270-751-9

270-752-4

270-754-5

269-628-2

1543

Xxxx[2-xxxxx-1-(xxxxxxxxxxx)xxxxx]xxxxxx

13674-87-8

237-159-2

1544

Xxxxxx xxxxx

22398-80-7

244-959-5

1545

Xxxxxxxx-xxxxxx

25155-23-1

246-677-8

1546

Xxxxxxxxxxxxxxxxxxxx [1]

25637-99-4 [1]

247-148-4 [1]

1,2,5,6,9,10-xxxxxxxxxxxxxxxxxxxx [2]

3194-55-6 [2]

221-695-9 [2]

1547

Xxxxxxxxxxxxxxx

109-99-9

203-726-8

1548

Xxxxxxxxx (xxxx xxxxxxxxxxx X1x x xxxxxxxxxxx X1x) (XXX) [1]

71751-41-2 [1]

615-339-5 [1]

xxxxxxxxxx X1x [2]

65195-55-3 [2]

265-610-3 [2]

1549

4-Xxxx-xxxxxxxxxxxxx xxxxxxxx

98-73-7

202-696-3

1550

Xxxxxxxxxxxxxxxx xxxxx; N,N,N′,N′-tetramethyl-4,4′-benzylidendianilin

129-73-7

204-961-9

1551

Fuberidazol (XXX); 2-(2-furyl)benzimidazol

3878-19-1

223-404-0

1552

Metazachlor (XXX); 2-xxxxx-X-(2,6-xxxxxxxxxxxxx)-X-(xxxxxxx-1-xxxxxxxx)xxxxxxxx

67129-08-2

266-583-0

1553

Xx-xxxx-xxxxxxxxxxxx

110-05-4

203-733-6

1554

Xxxxxxxxxxxxxxxxxxxxx

993-16-8

213-608-8

1555

2-Xxxxxxxxxx-10-xxxxx-4-[[2-[(2-xxxxxxxxxx)xxx]-2-xxxxxxxx]xxxx]-4-xxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx

57583-34-3

260-828-5

1556

2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)

15571-58-1

239-622-4

1557

Xxxxxxxxxx (XXX); 2-[2-chlor-4-(methylsulfonyl)benzoyl]cyklohexan-1,3-dion

99105-77-8

619-394-6

1558

Bifenthrin (XXX); (2-xxxxxxxxxxxxx-3-xx)xxxxxx-xxx-(1X,3X)-3-[(1X)-2-xxxxx-3,3,3-xxxxxxxxxxxx-1-xx-1-xx]-2,2-xxxxxxxxxxxxxxxxxxx-xxxxxxxxxx

82657-04-3

617-373-6

1559

Xxxxxxx-xxxxxx

84-75-3

201-559-5

1560

Xxxxxxx-xxxxxxxxxxxxxxxxxxxxxx

3825-26-1

223-320-4

1561

Xxxxxxxxxxxxxxxx kyselina

335-67-1

206-397-9

1562

N-ethyl-2-pyrrolidon; 1-xxxxxxxxxxxxxxx-2-xx

2687-91-4

220-250-6

1563

Xxxxxxxxxxx (XXX); 6-xxx-2-xxxxxxx-3-xxxxxxxxxxxxxxxx-4(3X)-xx

189278-12-4

606-168-7

1564

Xxxxxxx xxxxx

1303-00-0

215-114-8

1565

Xxxxx-xxxxxx

108-05-4

203-545-4

1566

Xxxxxxxxx (ISO); 2-xxxxx-3-xxxxxx-6-xxxxxxxxxxx

74070-46-5

277-704-1

1567

2-Xxxxxxxxxx-(10-xxxxx-4,4-xxxxxxxx-7-xxx-8-xxx-3,5-xxxxxx-4-xxxxxxxxxxxxxxxxxxx)

57583-35-4

260-829-0

1568

Xxxxxxxxxxxxxxx-xxxxxxxxx

753-73-1

212-039-2

1569

4-Xxxxxxxxxxxxxxx

100-40-3

202-848-9

1570

Xxxxxxxxxxx (XXX); 2-(X-xxxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-xxxxxxxxxxxxxxx-2-xx-1-xx

87820-88-0

618-075-9

1571

Xxxxxxxxxx (ISO); 2-(X-xxxxxxxxxxxxxxxxxx)-3-xxxxxxx-5-(xxxxxxxxxx-2X-xxxxxxxxx-3-xx)xxxxxxxx-2-xx-1-xx

101205-02-1

405-230-9

1572

Xxxxxxxxx (XXX); 3-xxxxx-X-[3-xxxxx-2,6-xxxxxxx-4-(xxxxxxxxxxxxxx)xxxxx]-5-(xxxxxxxxxxxxxx)xxxxxxx-2-xxxx

79622-59-6

616-712-5

1573

Xxxxxxxxxx (XXX); 1-[2-(2,4-xxxxxxxxxxxx)xxxxxx]-1X-1,2,4-xxxxxxx

66246-88-6

266-275-6

1574

Xxxxxxxxxx (XXX); xxxxx-X-[2-(4-xxxxxxxxxxxx)xxxxx]xxxxxxxx

72490-01-8

276-696-7

1575

Xxxxxx

100-42-5

202-851-5

1576

2-(Xxxxxxxxxxxxx)xxxxxxxxxxxxxxx; xxxxxxxxxxxxxxxxxxxxxxxxx

97-99-4

202-625-6

1577

Xxxxxxxxxxx

50-00-0

200-001-8

1578

Xxxxxxxxxxxxxxx

30525-89-4

608-494-5

1579

Xxxxxxxxxx, xxxxxxxxxxxxxx

463-57-0

207-339-5

1580

Xxxxxxxxx (XXX); 1-xxxxx-3-[2-xxxx-2-(xxxxxxxxxxxx)xxxxxx]xxxxxxxx

57966-95-7

261-043-0

1581

Xxxxxxxxxxxxxxx, xxxxxxxxxx

—

—

1582

Xxxxxxxxxx (XXX); 2-{2-xxxxx-4-(xxxxxxxxxxxxxx)-3-[(2,2,2-xxxxxxxxxxxxxx)xxxxxx]xxxxxxx}xxxxxxxxxx-1,3-xxxx

335104-84-2

608-879-8

1583

1,2-Xxxxxxxxxxxxxxxxxxx xxxxxxxx, xxxxxxxxxxxx, rozvětvený a xxxxxxxx

68515-50-4

271-093-5

1584

Xxxxxxxxxxxxx (XXX); (5x,8x)-3-(2,5-xxxxxxxxxxxxx)-8-xxxxxxx-2-xxx-1-xxxxxxxx[4,5]xxx-3-xx-4-xx-xxxxxxxxxxxxx

203313-25-1

606-523-6

1585

Xxxxxxxx-xxxxxx; 4-xxxxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx-4-xxx-xxxxxx

31717-87-0

250-778-2

1586

Xxxxxxxxxxxxxx-xxxxxx; xxxxxx-2-([4-(xxxxxxxxxxxxx)-6-(2,2,2-xxxxxxxxxxxxxx)-1,3,5-xxxxxxx-2-xx]xxxxxxxxxxxxxxxxxx)-3-xxxxxxxxxxxxx

126535-15-7

603-146-9

1587

Xxxxxxxx (ISO); 1-[2-xxxxxxxx-2-(2,4-xxxxxxxxxxxx)xxxxx]-1X-xxxxxxxx

35554-44-0

252-615-0

1588

Xxxxxxxx (XXX); 4-xxxxxxxxxx-2,6-xxxxxxxxxxxxxxxx

1593-77-7

216-474-9

1589

Xxxxxxxx

288-32-4

206-019-2

1590

Xxxxxxx (XXX); 3-xxxxxxxxxx-6,7-xxxxxxx-1X-xxxxxxxxxx[x]xxxxxxxxx-2,4(3X,5X)-xxxx

2164-08-1

218-499-0

1591

Xxxxxxxxx (XXX); X-(2,6-xxxxxxx-3-xxxxxxxxxxx)-5,7-xxxxxxxxx[1,2,4]xxxxxxxx[1,5-x]xxxxxxxxx-2-xxxxxxxxxx

139528-85-1

604-145-6

1592

2-Xxxxxx-1-(4-xxxxxxxxxxxxxxx)-2-xxxxxxxxxxxxxxx 1-xx

71868-10-5

400-600-6

1593

2,3-Xxxxxxxxxxx-xxxxxxxxxxx

106-91-2

203-441-9

1594

Xxxxxxxxxx (XXX) 8-xxxx-xxxxx-1,4-xxxxxxxxxx[4.5]xxxxx-2-xxxxxxxx(xxxxx)(xxxxxx)xxxx

118134-30-8

601-505-4

1595

Xxxxxxxx; karbonitril

420-04-2

206-992-3

1596

Cyprokonazol (ISO); (2XX,3XX;2XX,3XX)-2-(4-xxxxxxxxxx)-3-xxxxxxxxxxx-1-(1X-1,2,4-xxxxxxx-1-xx)xxxxx-2-xx

94361-06-5

619-020-1

1597

Xxxxxxxx-xxxxxxxxx xxxxxx

130328-20-0

603-404-0

1598

Xxxxxxxxx xxxxxxxxx

513-78-0

208-168-9

1599

Xxxxxxxx xxxxxxxxx

21041-95-2

244-168-5

1600

Xxxxxxxx kademnatý

10325-94-7

233-710-6

1601

Dibutylcín-dilaurát xxxxxxx[xxx(xxxxxxxxxxxxx)]xxxxxxx

77-58-7

201-039-8

1602

Xxxxxxxxx; 2-xxxxxx-4-xxxxxxxxxx

120-32-1

204-385-8

1603

Xxxxxxxxxxxx

84-65-1

201-549-0

1604

Xxxxxxxxxxxxxxxxxxxxx xxxxxxxx [1]

335-76-2 [1]

206-400-3[1]

xxxxxxx-xxxxxxxxxxxxxxxxxxxxx [2]

3108-42-7 [2]

221-470-5 [2] [3]

xxxxxx-xxxxxxxxxxxxxxxxxxxxx [3]

3830-45-3 [3]

1605

X,X′-xxxxxxxxxxxxxxxxxx; N,N′-methylenbismorfolin; [xxxxxxxxxxx xxxxxxxx x N,N′-methylenebismorfolinu]; [XXX]

xxxxx maximální teoretická xxxxxxxxxxx xxxxxxxxxxxxx formaldehydu xxx ohledu na xxxxx je ve xxxxx, jak je xxxxxxx na xxx, ≥ 0,1 % xxxxxxxxxxxx

5625-90-1

227-062-3

1606

Xxxxxxx xxxxxxxx paraformaldehydu x 2-xxxxxxxxxxxxxxxxxxx (3:2);

[formaldehyd xxxxxxxx z 3,3′-methylenbis [5–xxxxxxxxxxxxxxxxx]; [xxxxxxxxxxx xxxxxxxx x oxazolidinu]; [MBO], xxxxx xxxxxxxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxxxxxx xxxxxxxxxxxx xxx ohledu xx xxxxx je ve xxxxx, xxx je xxxxxxx na trh, ≥ 0,1 % xxxxxxxxxxxx

—

—

1607

Xxxxxxx xxxxxxxx xxxxxxxxxxxxxxxx x 2-hydroxypropylaminem (1:1);

[formaldehyd xxxxxxxx x α,α,α-xxxxxxxxx-1,3,5-xxxxxxx-1,3,5 (2X,4X,6X)-xxxxxxxxxxx]; [XXX], pokud xxxxxxxxx teoretická xxxxxxxxxxx xxxxxxxxxxxxx formaldehydu xxx xxxxxx na xxxxx xx ve xxxxx, xxx xx xxxxxxx xx xxx, ≥ 0,1 % xxxxxxxxxxxx

—

—

1608

Xxxxxxxxxxxxxx

60-34-4

200-471-4

1609

Xxxxxxxxxxx (XXX); (1RS,2RS;1RS,2RS)-1-(4-chlorfenoxy)-3,3-dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol); α-xxxx-xxxxx-β-(4-xxxxxxxxxxxx)-1X-1,2,4-xxxxxxx-1-xxxxxxx

55219-65-3

259-537-6

1610

Xxxxxxxxxxx (XXX); (X)-3-(6-xxxxx-3-xxxxxxxxxxxxx)-1-3-xxxxxxxxxxx-2-xxxxxxxxxxxxxx; {(2X)-3-[(6-xxxxxxxxxxxx-3-xx)xxxxxx]-1,3-xxxxxxxxxxx-2-xxxxxx}xxxxxxxx

111988-49-9

601-147-9

1611

Xxxxxxxxxx (XXX); (X)-1-(xxxxxxxxxxxxxx)xxxxxxxxxxxxxxx (2R)-1-(ethylamino)-1-oxopropan-2-yl-fenylkarbamát

16118-49-3

240-286-6“

b)

položka 395 se xxxxxxxxx xxxxx:

Xxxxxxxxxx číslo

Identifikace xxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx CAS

Číslo XX

„395

Xxxxxxxx-8-xx x xxxx sulfát

148-24-2

134-31-6

205-711-1

205-137-1“

2)   

Příloha XXX xx xxxx xxxxx:

x)

xxxxxxx 1a, 1b, 7, 13 x&xxxx;51 xx xxxxxxx;

x)

xxxxxxx 12 xx nahrazuje xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx látky

Omezení

Znění xxxxxxxx xxxxxxx a xxxxxxxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx x xxxxxxx xxxxxx podle xxxxxxxx xxxxxxxxxxxx

Xxxxx CAS

Číslo ES

Druh xxxxxxx, xxxxx xxxx

Xxxxxxxx xxxxxxxxxxx v přípravku xxxxxxxxxxx x xxxxxxx

Xxxx

x

x

x

x

x

x

x

x

x

„12

Xxxxxxx xxxxxx x ostatní xxxxxxxxxx nebo xxxxx, xxxxx xxxxxxx xxxxxx xxxxxxxx, xxxxxx látek xxxxxxxx xxxxxxx x xxxxxxx xxxxxxxxx, s xxxxxxxx xxxxxx látek x xxxxxxx II:

—

č. 1397, 1398, 1399

Hydrogen xxxxxxxx

7722-84-1

231-765-0

x)

Xxxxxxxxx na xxxxx

x)

12 % X2X2 (40 xxxxxx), xxxxxxxxxx nebo xxxxxxxxxx

x) f) Xxxxxxxxxx xxxxxx rukavice.

a) x) x) x)

Xxxxxxxx xxxxxxx xxxxxx.

Xxxxxxxx xxxxx s xxxxx.

Xxx zasažení xxx xxxxxxxx xxxxxxxxxxx xxxxx.

x)

Xxxxxxxxx xx xxxx

x)

4 % X2X2, xxxxxxxxxx xxxx xxxxxxxxxx

x)

Xxxxxxxxx xxx xxxxxxx xxxxx

x)

2 % H2O2, xxxxxxxxxx nebo uvolněného

d)

Přípravky xxx ústní hygienu, xxxxxx xxxxx xxxx, xxxxx xxxxx a xxxxxxxxx na bělení xxxx zesvětlení zubů

d)

≤ 0,1 % H2O2, xxxxxxxxxx xxxx xxxxxxxxxx

x)

Xxxxxxxxx xx xxxxxx nebo xxxxxxxxxx xxxx

x)

&xx; 0,1 % ≤ 6 % X2X2, xxxxxxxxxx xxxx uvolněného

e)

K xxxxxxx xxxxx zubním lékařům. X xxxxxxx cyklu xxxxxxx xxxx xxx xxxxx xxxxxxx xxxxxxxxx xxxxxx lékařem xx xxxxxx směrnice Xxxxxxxxxx xxxxxxxxxx x Rady 2005/36/XX&xxxx;(*1) nebo pod xxxx xxxxxx xxxxxxxx, xxxxx je zaručena xxxxxxxxxx xxxxxx xxxxxxxxxxx.

Xxxx xxxxxx xxxxxxxxxxxx k xxxxxxxxx xxxxx xxxxxxx.

Xxxxxxxxxx x xxxx xxxxxxxx 18 let.

e)

Koncentrace H2O2 xxxxxxxxxx nebo xxxxxxxxxx xxxxxxx x procentech.

Nepoužívat x xxxx mladších 18 let.

K prodeji xxxxx zubním lékařům. X xxxxxxx xxxxx xxxxxxx musí xxx xxxxx použití provedeno xxxxx xxxxxx lékařem xxxx xxx xxxx xxxxxx dohledem, xxxxx xx xxxxxxxx xxxxxxxxxx xxxxxx bezpečnosti.

Poté předat xxxxxxxxxxxx x dokončení xxxxx xxxxxxx.

x)

Xxxxxxxxx určené xxx řasy

f)

2 % X2X2, přítomného xxxx xxxxxxxxxx

x)

Xxx pro xxxxxxxxxxxxx xxxxxxx.

x)

Xx xxxxxxx xx xxxxx:

„Xxx xxx profesionální xxxxxxx.

Xxxxxxxx styku x xxxxx.

Xxx xxxxxxxx očí xxxxxxxx xxxxxxxxxxx vodou.

Obsahuje xxxxxxx xxxxxx.“

x)

xxxxxxxx xx xxxx položky, xxxxx xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxx

Xxxxx xxxxxxxx xxxxxxx x xxxxxxxxxx

Xxxxxxxx xxxxx/

XXX

Xxxxx v xxxxxxx xxxxxx xxxxx xxxxxxxx nomenklatury

Číslo XXX

Xxxxx XX

Xxxx xxxxxxx, xxxxx xxxx

Xxxxxxxx koncentrace v xxxxxxxxx xxxxxxxxxxx x xxxxxxx

Xxxx

x

x

x

x

x

x

x

x

x

„311

Xxxxxxx(2,4,6-xxxxxxxxxxxxxxx)xxxxxx xxxx

Xxxxxxxxxxxxxxxx diphenylphosphine xxxxx

75980-60-8

278-355-8

Xxxxxxx xxxxxxx xxxxx

5,0 %

Xxxxxxxxxxxxx použití

Jen xxx xxxxxxxxxxxxx xxxxxxx.

Xxxxxxxx xxxxx x kůží.

Čtěte xxxxxxx xxxxx x xxxxxxx.

312

2-Xxxxxxxxxx

Xxxxxxxx

98-01-1

202-627-7

0,001 %“

3)&xxxx;&xxxx;&xxxx;

Xxxxxxx X&xxxx;xx xxxx xxxxx:

x)

x&xxxx;xxxxx se bod 2 nahrazuje tímto:

„2.

 Veškeré xxxxxxx xxxxxxx obsahující xxxxx xxxxxxx x&xxxx;xxxx xxxxxxx, x&xxxx;xxxxx xx xxxxxxxx xxxxxxxxxxx, xxxx xxx xxxxxxxx upozorněním „xxxxxxxx xxxxxxxxxxx“, jestliže xxxxxxxxxxx xxxxxxxxxxxx x&xxxx;xxxxxxxx xxxxxxx xxxxxxxx 0,05&xxxx;%.“;

x)

xxxxxxx 5, 31, 40 x&xxxx;41 xx xxxxxxx;

x)

xxxxxxx 28 xx nahrazuje xxxxx:

Xxxxxxxxxx xxxxx

Xxxxxxxxxxxx xxxxx

Xxxxxxxx

Xxxxx xxxxxxxx xxxxxxx a xxxxxxxxxx

Xxxxxxxx xxxxx/XXX

Xxxxx v xxxxxxx přísad xxxxx xxxxxxxx xxxxxxxxxxxx

Xxxxx XXX

Xxxxx XX

Xxxx xxxxxxx, xxxxx xxxx

Xxxxxxxx xxxxxxxxxxx x xxxxxxxxx připraveném k xxxxxxx

Xxxx

x

x

x

x

x

x

x

x

x

„28

Xxxxxxxxxxxxxxxx-xxxxxxxx-xxxxxxxxxxxx

Xxxxxxxxxxxxxxx biguanide

32289-58-0,

27083-27-8,

28757-47-3,

133029-32-0

608-723-9

608-042-7

0,1 %

Xxxxxxxxxx x xxxxxxxxxx, xxx xxxxx xxxx k xxxxxxxx plic xxxxxxxxx xxxxxxxxx při xxxxxxxxxx.“

(*1)&xxxx;&xxxx;Xxxxxxxx Xxxxxxxxxx xxxxxxxxxx x Xxxx 2005/36/XX xx xxx 7. září 2005 x xxxxxxxx xxxxxxxxx xxxxxxxxxxx (Úř. xxxx. X&xxxx;255, 30.9.2005, x.&xxxx;22).“